uric acid has been researched along with Hyperlipemia in 335 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to compare urate-lowering (UL) efficacy and safety of daily febuxostat and allopurinol in subjects with gout and serum urate (sUA) > or = 8." | 9.14 | The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial. ( Becker, MA; Espinoza, LR; Lademacher, C; Lloyd, E; MacDonald, P; Schumacher, HR; Wells, AF, 2010) |
| "Many large epidemiologic studies have confirmed a positive association between raised serum uric acid and risk of coronary heart disease or cardiovascular disease, both in the general population and among hypertensive patients." | 8.81 | Serum uric acid is not an independent risk factor for coronary heart disease. ( Wannamethee, SG, 2001) |
| "The role of uric acid as an independent risk factor in the development of coronary heart disease (CHD) has been questioned as serum urate is related to many of the established etiological risk factors for cardiovascular disease which could confound the observed association." | 8.80 | Is serum uric acid a risk factor for coronary heart disease? ( Wannamethee, SG, 1999) |
| "Accumulating evidence suggests that elevated serum uric acid (SUA) may be a risk factor for hypertriglyceridemia (HTG)." | 8.31 | The association between serum uric acid and hypertriglyceridemia: evidence from the national health and nutrition examination survey (2007-2018). ( Li, F; Mo, CY; Tan, MY; Zhao, Q, 2023) |
| " The GREek Atorvastatin and Coronary-heart-disease Evaluation study suggested that a mean atorvastatin dose of 24 mg/d achieves the National Cholesterol Educational Program treatment goals and significantly reduces morbidity and mortality in patients with coronary heart disease (CHD) in comparison to the usual care." | 7.72 | Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. ( Athyros, VG; Bouloukos, VI; Elisaf, M; Mikhailidis, DP; Milionis, HJ; Papageorgiou, AA; Pehlivanidis, AN; Symeonidis, AN, 2004) |
| "Plasma fibrinogen content was measured in 20 normal subjects, 20 patients with diabetes mellitus, 20 patients with hyperlipoproteinemia type II or IV (Fredrickson) and 10 patients with hyperuricemia." | 7.65 | [Plasma fibrinogen activity in diabetes mellitus, hyperlipoproteinemia and hyperuricemia (author's transl)]. ( Gross, W; Zöller, H, 1976) |
| "23 patients with hyperlipidemia and hyperuricemia received acetamidoethyl-(4-chlorophenyl)-(trifluoromethylphenoxy)-acetate (halofenate), a clofibrate derivative, and probenecid or probenecid and placebo over 36 weeks following a placebo period of 6 weeks." | 6.64 | [Treatment of hyperlipemia and hyperuricemia with 2-acetamidoethyl-(4-chlorophenyl)-(3-trifluoromethylphenoxy)-acetate (halofenate), a derivative of clofibrate]. ( Keller, C; Wolfram, G; Zöllner, N, 1976) |
| "In the present study, 841 NAFLD males (30-75 years) were recruited from a Chinese prospective cohort study (PMMJS) and followed up for five years." | 5.43 | Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males. ( Dong, C; Guo, Z; Liu, C; Qiu, J; Song, K; Wang, Y; Xu, Y; Zhang, B; Zhou, H; Zhou, Z, 2016) |
| "Uric acid (UA) was thought to induce cardiomyocyte growth and interstitial fibrosis of the heart, partly via activation of the renin-angiotensin system." | 5.35 | Uric acid and left ventricular hypertrophy in Japanese men. ( Hotta, Y; Kondo, T; Matsushita, K; Mitsuhashi, H; Muramatsu, T; Murohara, T; Otsuka, R; Takefuji, S; Tamakoshi, K; Toyoshima, H; Yatsuya, H; Zhang, H, 2009) |
| "Asymptomatic hyperuricemia is not a current indication for therapy as the definite role of serum uric acid elevation as a cardiovascular risk factor is extremely likely but still controversial." | 5.22 | Effects of a Novel Fixed Combination of Nutraceuticals on Serum Uric Acid Concentrations and the Lipid Profile in Asymptomatic Hyperuricemic Patients : Results from the PICONZ-UA Study. ( Ferri, C; Grassi, D; Izzo, R; Rozza, F; Trimarco, V, 2016) |
| "The purpose of this study was to compare urate-lowering (UL) efficacy and safety of daily febuxostat and allopurinol in subjects with gout and serum urate (sUA) > or = 8." | 5.14 | The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial. ( Becker, MA; Espinoza, LR; Lademacher, C; Lloyd, E; MacDonald, P; Schumacher, HR; Wells, AF, 2010) |
| "A total of 116 patients with hypertriglyceridemia and hyperuricemia received 200 mg micronised fenofibrate for 4 weeks." | 5.14 | [Effects of micronized fenofibrate on lipid and uric acid metabolism in patients with hyperlipidemia]. ( Chen, H; Li, LJ; Luo, Y; Ren, JY; Wang, L, 2009) |
| " Early markers of CVD such as microalbuminuria and uric acid levels need to be added to the routine annual evaluation, particularly among high-risk individuals such as diabetics, hypertensives, smokers, and the elderly." | 4.85 | Chronic kidney disease: a marker of cardiovascular disease. ( Nguyen, PT; Olivero, JJ, 2009) |
| "Many large epidemiologic studies have confirmed a positive association between raised serum uric acid and risk of coronary heart disease or cardiovascular disease, both in the general population and among hypertensive patients." | 4.81 | Serum uric acid is not an independent risk factor for coronary heart disease. ( Wannamethee, SG, 2001) |
| "The role of uric acid as an independent risk factor in the development of coronary heart disease (CHD) has been questioned as serum urate is related to many of the established etiological risk factors for cardiovascular disease which could confound the observed association." | 4.80 | Is serum uric acid a risk factor for coronary heart disease? ( Wannamethee, SG, 1999) |
| "The therapy of gout is discussed taking into consideration the concomitant diseases occurring significantly frequently in patients with gout: Hypertension, uric acid-nephrolithiasis, hyperlipoproteinaemia, obesity, premature arteriosclerosis as well as diabetes mellitus." | 4.75 | [Therapy of gout]. ( Heidelmann, G; Thiele, P, 1977) |
| "Studies have shown that elevated serum uric acid (SUA) may increase the risk of coronary heart disease (CHD)." | 4.31 | Mediating effect of metabolic diseases on the relationship between hyperuricemia and coronary heart disease. ( Bai, Y; Chen, Y; Cheng, Z; Hu, Y; Li, J; Li, S; Wang, Y; Xu, L; Yin, C, 2023) |
| "Accumulating evidence suggests that elevated serum uric acid (SUA) may be a risk factor for hypertriglyceridemia (HTG)." | 4.31 | The association between serum uric acid and hypertriglyceridemia: evidence from the national health and nutrition examination survey (2007-2018). ( Li, F; Mo, CY; Tan, MY; Zhao, Q, 2023) |
| "Children in the dyslipidemia group had more severe clinical characteristics (higher blood urea nitrogen, serum uric acid, and 24-h proteinuria; higher proportion of hypertension; and lower serum albumin and estimated glomerular filtration rate) and pathological changes (higher proportion of Lee grades IV-V and E1, S1, and C2 in MEST-C)." | 4.12 | Dyslipidemia may be a risk factor for progression in children with IgA nephropathy. ( Chen, L; Jiang, M; Jiang, X; Lin, Z; Xu, Y; Zeng, S; Zhuang, H, 2022) |
| "HHcy: hyperhomocysteinemia; Hcy: homocysteine; VLDL: very low-density lipoprotein; CVD: cardiovascular disease; SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; ALT: alanine aminotransferase; Cr: creatinine; UA: uric acid; TG: triglycerides; TC: total cholesterol; HDL: high-density lipoprotein; LDL: low-density lipoprotein; FBG: fasting blood glucose; CRP: C-reactive protein; MTHFR: methylene tetrahydrofolate reductase; NO: nitric oxide; HDL-C: high-density lipoprotein cholesterol." | 4.02 | Association of serum VLDL level with hyperhomocysteinemia in hypertensive patients: A cross-sectional study. ( Chen, J; Hong, X; Li, J; Wang, J; Wu, M; Zeng, D; Zhang, D; Zhang, Y, 2021) |
| "Elevated serum uric acid concentration was strongly associated with obesity and hyperlipidemia in both men and women." | 3.81 | Relationship Between Hyperuricemia and Cardiovascular Disease Risk Factors in a Chinese Population: A Cross-Sectional Study. ( Hong, L; Li, L; Su, P; Sun, H; Zhao, Y, 2015) |
| "Serum uric acid levels have been reported to be associated with non-alcoholic fatty liver disease (NAFLD)." | 3.80 | Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women. ( Chen, Y; Liu, PJ; Lou, HP; Ma, F; Zhu, YN, 2014) |
| "Previous reports suggested that gout incidence increased with serum uric acid (sUA) level." | 3.78 | Gender-specific risk factors for incident gout: a prospective cohort study. ( Chen, JH; Chuang, SY; Pan, WH; Wu, YY; Yeh, WT, 2012) |
| "The aim of this study was to examine the independent relationship between serum uric acid (SUA) and blood pressure, and to assess their joint effects on obesity, fasting glucose and lipids." | 3.77 | Interaction between serum uric acid and triglycerides in relation to blood pressure. ( Liang, J; Song, H; Teng, F; Xue, Y; Yang, M; Zhu, R; Zou, C, 2011) |
| " The biochemical analysis showed only a discrete hyperlipemia and a rise in plasma uric acid levels in the transgenic mice." | 3.76 | Overexpression of podocalyxin in megakaryocytes and platelets decreases the bleeding time and enhances the agonist-induced aggregation of platelets. ( Alonso-Martin, S; Ayuso, MS; Fernández, D; Larrucea, S; Nowakowski, A; Parrilla, R; Vilar-Egea, M, 2010) |
| " The GREek Atorvastatin and Coronary-heart-disease Evaluation study suggested that a mean atorvastatin dose of 24 mg/d achieves the National Cholesterol Educational Program treatment goals and significantly reduces morbidity and mortality in patients with coronary heart disease (CHD) in comparison to the usual care." | 3.72 | Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. ( Athyros, VG; Bouloukos, VI; Elisaf, M; Mikhailidis, DP; Milionis, HJ; Papageorgiou, AA; Pehlivanidis, AN; Symeonidis, AN, 2004) |
| " The diabetic dams presented hyperglycemia, hyperlipemia, hypertriglyceridemia, hypercholesterolemia, hyperuricemia, decreased reduced glutathione (GSH), hepatic glycogen and superoxide dismutase (SOD) determinations." | 3.71 | Oxidative stress and diabetes in pregnant rats. ( Cunha Rudge, MV; Damasceno, DC; de Mattos Paranhos Calderon, I; Volpato, GT, 2002) |
| " It has been proposed that the elevated serum uric acid levels are linked to other risk factors, such as hypertension, dyslipidaemia and diabetes." | 3.70 | Management of hypertension and dyslipidaemia in patients presenting with hyperuricaemia: case histories. ( Elisaf, MS; Milionis, HJ, 2000) |
| "Stroke was significantly associated with hypertension and high values of plasma glucose but not with fibrinogen, factor VIIc, or factor VIIIc." | 3.69 | Associations between carotid atherosclerosis and high factor VIII activity, dyslipidemia, and hypertension. ( Bai, CH; Chen, JR; Chiu, HC; Pan, WH, 1997) |
| "Systolic blood pressure, diastolic blood pressure, serum cholesterol, serum uric acid, past history of illness, present illness, body mass index (BMI: weight/height2 (kg/m2)), indices of weight change (the intrapersonal standard deviation of BMI (ISD), the coefficient of variation of BMI (CV), the root mean square error of variation (RMSE) around the slope of BMI vs age, weight change categories (cycler, weight gainer, no changer, etc." | 3.69 | An evaluation of various indices of body weight change and their relationship with coronary risk factors. ( Horie, S; Itoh, T; Okubo, T; Takahashi, K, 1996) |
| "Behavioural and biological correlates of serum uric acid were investigated in 2487 men who received a retirement health examination at the Self-Defence Forces Fukuoka Hospital from October 1986 through 1990, excluding those under medication for hyperuricaemia, hypertension or hyperlipidaemia." | 3.69 | Behavioural and biological correlates of serum uric acid: a study of self-defence officials in Japan. ( Honjo, S; Imanishi, K; Kono, S; Shinchi, K; Todoroki, I, 1994) |
| "We carried out a study of 43 male asymptomatic subjects with high levels of uric acid but showing no signs of arterial hypertension, obesity or alcohol abuse." | 3.68 | Hyperuricemia-hyperlipemia association in the absence of obesity and alcohol abuse. ( Añon Barbudo, J; Collantes Estevez, E; Pineda Priego, M; Sanchez Guijo, P, 1990) |
| "Plasma fibrinogen content was measured in 20 normal subjects, 20 patients with diabetes mellitus, 20 patients with hyperlipoproteinemia type II or IV (Fredrickson) and 10 patients with hyperuricemia." | 3.65 | [Plasma fibrinogen activity in diabetes mellitus, hyperlipoproteinemia and hyperuricemia (author's transl)]. ( Gross, W; Zöller, H, 1976) |
| "Healthy virgin and breeder rats (Sprague-Dawley) with naturally occurring hypertension and arteriosclerosis were fed 5% oxonic acid and 1% uric acid added to their regular diet for 30 days." | 3.65 | Effect of increased serum urate levels on virgin rats with no arteriosclerosis versus breeder rats with preexistent arteriosclerosis. ( Greenberg, BP; Wexler, BC, 1977) |
| "70 patients with hyperlipemias of various types were treated perorally with 350 mg Mg-chlorophenoxyisobutyrate, and 250 mg of mesoinositol-hexanicotinate (Atroplex) three times daily." | 3.65 | [Clinical study with a new antihyperlipemic combination]. ( Pistautz, H, 1977) |
| " 91% have serum uric acid levels above the normal range and 61% present "hyperuricemia," according to "gouty risk" criteria." | 3.65 | [Occurrence of hyperuricemia in atrioventricular block. (Results of a study of 158 patients with isotopic pacemaker implantations)]. ( Gavelle, P; Laurens, P; Maurice, P, 1976) |
| " Data on blood pressure, obesity and serum lipids are presented here, and are discussed together with smoking and serum uric acid." | 3.65 | Coronary risk factors in New Zealand Maori and European adolescents: The Rotoua Lakes Study 2. ( Malcolm, JB; Stanhope, JM, 1975) |
| " In 2 cases a mild diabetes mellitus, in 7 cases uric acid level in serum was raised." | 3.65 | [Clinical-neurological and electromyographical studies of inpatients isolated with selective pigmentary retinopathy]. ( Eickhoff, W; Hellner, KA; Müller-Jensen, A, 1975) |
| "In CKD patients with dyslipidemia, hyperuricemia was an independent risk factor for CKD progression." | 2.94 | The association between uric acid levels and renal function of CKD patients with hyperlipidemia: a sub-analysis of the ASUCA trial. ( Kasahara, M; Kuwabara, Y; Nakao, K; Ueshima, K; Yasuno, S, 2020) |
| "Patients with combined hyperlipidemia (n = 37) were randomized to receive 9 weeks of treatment with micronized fenofibrate 200 mg/day (F group) or fenofibrate 200 mg/day plus folic acid 10 mg/every other day (F+F group)." | 2.71 | Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine. ( Ceska, R; Grauova, B; Haas, T; Hradec, J; Kozich, V; Krijt, J; Malik, J; Melenovsky, V; Stulc, T; Wichterle, D, 2003) |
| "Fenofibrate treatment did not cause any change in the serum xanthine and hypoxanthine concentrations." | 2.71 | Effect of fenofibrate on uric acid metabolism in Japanese hyperlipidemic patients. ( Fuse, M; Noguchi, Y; Otsuka, Y; Saito, Y; Shibata, T; Suyama, K; Takeo, C; Tatsuno, I; Yoshida, T, 2004) |
| "Twenty-two patients suffering from hyperlipidemia and receiving therapy consisting of a lipid-lowering diet and clofibrate (1 g X 2) were in addition given colestipol hydrochloride (5 g X 3) (Colestid, Upjohn) in a randomized, cross-over study for 2 periods of 6 weeks." | 2.65 | The effects of colestipol when combined with clofibrate in the treatment of severe hyperlipidemia. Short-term and long-term studies. ( Boberg, J; Hellsing, K; Lithell, H; Vessby, B, 1980) |
| "Halofenate is a new antilipemic drug which is an ester of carboxylic acid." | 2.64 | The metabolic spectrum of halofenate. ( Ryan, JR, 1975) |
| "23 patients with hyperlipidemia and hyperuricemia received acetamidoethyl-(4-chlorophenyl)-(trifluoromethylphenoxy)-acetate (halofenate), a clofibrate derivative, and probenecid or probenecid and placebo over 36 weeks following a placebo period of 6 weeks." | 2.64 | [Treatment of hyperlipemia and hyperuricemia with 2-acetamidoethyl-(4-chlorophenyl)-(3-trifluoromethylphenoxy)-acetate (halofenate), a derivative of clofibrate]. ( Keller, C; Wolfram, G; Zöllner, N, 1976) |
| "of clofibrate was studied in 29 subjects with different types of hyperlipoproteinaemia in a single blind crossover fashion." | 2.64 | Effect of BM 15.075 on lipoprotein concentrations in different types of hyperlipoproteinaemia. ( Carlson, LA; Lang, PD; Olsson, AG; Rössner, S; Walldius, G, 1977) |
| "Uric acid was significantly reduced only during the first period of treatment (p less than 0." | 2.64 | Clofibrate in type II hyperlipoproteinemia. ( Bang, HO; Ditzel, J, 1976) |
| "The association between gout and type 2 diabetes, hypertension, hyperlipidemia, cardiovascular disease, renal disease, and obesity suggest that either gout, or its necessary precursor hyperuricemia, may play an important role in the manifestations of the metabolic syndrome." | 2.55 | Gout and Metabolic Syndrome: a Tangled Web. ( Krasnokutsky, S; Pillinger, MH; Thottam, GE, 2017) |
| "Hypertension and hyperlipidemia, which are also responsible for cardiovascular diseases, are often associated with hyperuricemia." | 2.44 | [Other antihyperuricemic agents]. ( Hisatome, I; Igawa, O; Ogino, K, 2008) |
| "One hundred sixty NIDDM patients who had undergone the clamp study were stratified into 5 groups according to the serum uric acid level." | 2.39 | [Hyperuricemia and insulin resistance]. ( Iwatani, M; Katsumori, K; Saeki, A; Wasada, T, 1996) |
| "Patients with gout are at a higher risk of cardiovascular disease, which is associated with hyperlipidemia." | 1.56 | Effects of Urate-Lowering Therapy on Risk of Hyperlipidemia in Gout by a Population-Based Cohort Study and on ( Chung, YL; Fang, YJ; Li, JR; Lim, YP; Lin, CL; Su, CY; Tien, N; Wu, TY, 2020) |
| " 67% abdominal obesity was found, decreasing at 53% after drinking the established dosage of juice." | 1.43 | Effect of consumption of tree tomato juice (Cyphomandra betacea) on lipid profile and glucose con centrations in adults with hyperlipidemia, Ecuador. ( Barahona, A; Bermeo, B; Chtivez, C; Freire, P; Mndez, J; Ortiz, K; Salas, H; Salazar-Lugo, R; Santamaria, M, 2016) |
| "In the present study, 841 NAFLD males (30-75 years) were recruited from a Chinese prospective cohort study (PMMJS) and followed up for five years." | 1.43 | Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males. ( Dong, C; Guo, Z; Liu, C; Qiu, J; Song, K; Wang, Y; Xu, Y; Zhang, B; Zhou, H; Zhou, Z, 2016) |
| "Metabolic syndrome was found in 2502 of 18,222 healthy Chinese people (16." | 1.43 | Correlation of the leucocyte count with traditional and non-traditional components of metabolic syndrome. ( Gao, BL; Su, BY; Tian, CF; Tong, YH; Zhao, XH; Zheng, Y, 2016) |
| "Hyperuricemia and hyperlipidemia have attracted attention as progression factors for chronic kidney disease (CKD)." | 1.40 | Effects on serum uric acid by difference of the renal protective effects with atorvastatin and rosuvastatin in chronic kidney disease patients. ( An, T; Hayashi, H; Kikkawa, A; Kose, E; Matsumoto, Y, 2014) |
| "Uric acid (UA) was thought to induce cardiomyocyte growth and interstitial fibrosis of the heart, partly via activation of the renin-angiotensin system." | 1.35 | Uric acid and left ventricular hypertrophy in Japanese men. ( Hotta, Y; Kondo, T; Matsushita, K; Mitsuhashi, H; Muramatsu, T; Murohara, T; Otsuka, R; Takefuji, S; Tamakoshi, K; Toyoshima, H; Yatsuya, H; Zhang, H, 2009) |
| "Hyperlipidemia provokes inversion of correlation between the levels of uric acid, apo-E and apo-C3." | 1.34 | [Uric acid, apo-E and apo-C3 correlation in normo- and hyperlipidemia]. ( Boĭko, ER; Boĭko, SG; Kaneva, AM; Ovechkin, AO; Potolitsyna, NN, 2007) |
| "Hyperlipidemia associated with nephrotic syndrome may play a role in the worsening of renal function." | 1.34 | Protective role of sulphated polysaccharides in abating the hyperlipidemic nephropathy provoked by cyclosporine A. ( Amudha, G; Josephine, A; Preetha, SP; Varalakshmi, P; Veena, CK, 2007) |
| "Stroke is a leading cause of mortality and subsequent serious long-term physical and mental disability among survivors." | 1.33 | Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals. ( Bairaktari, ET; Elisaf, MS; Goudevenos, J; Liberopoulos, E; Milionis, HJ; Seferiadis, K, 2005) |
| "Uric acid and lipemia under physiological conditions did not interfere with NBT reaction." | 1.31 | A convenient assay of glycoserum by nitroblue tetrazolium with iodoacetamide. ( Chen, JW; He, RQ; Lin, XH; Liu, W; Wu, XQ; Xu, YJ, 2002) |
| "To know the prevalence of phenotypic dyslipidemias and their clinical and metabolic characteristics in recently diagnosed hypertensive patients." | 1.31 | [Prevalence of dyslipidemia and its phenotypes in recently diagnosed essential arterial hypertension]. ( García-Morillo, S; Miranda, ML; Montilla, C; Pamies, E; Stiefel, P; Villar, J, 2000) |
| "13 patients had combination of hyperinsulinemia with obesity, dyslipidemia, arterial hypertension." | 1.30 | [Urate affection of kidneys and metabolic disturbances in hypertensive patients]. ( Anikina, SA; Balkarov, IM; Donskov, AS; Fadina, ZM; Feofanova, ID; Golub', GV; Goncharov, VS; Saltykova, NG, 1999) |
| "Insulin resistance was estimated by homeostasis model assessment (HOMA(IR)), preliminarily validated against a euglycemic-hyperinsulinemic clamp in 85 subjects." | 1.30 | Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. ( Alberiche, M; Bonadonna, RC; Bonora, E; Egger, G; Kiechl, S; Muggeo, M; Oberhollenzer, F; Targher, G; Willeit, J, 1998) |
| "Both the hyperlipidemia and the hyperuricaemia were primary inasmuch as none of the patients studied was obese or had an above-normal alcohol intake or blood hypertension." | 1.28 | Renal excretion of urate by hyperuricaemic-hyperlipidemic patients. ( Añón Barbudo, J; Collantes Estevéz, E; González Ruiz, A; Pineda Priego, M; Sánchez Guijo, P; Tinahones Madueño, FJ, 1992) |
| "Cigarette smoking, hypertension, dyslipidemia, heredity, diabetes mellitus, obesity, beta blockades, and coronary artery bypass surgery are some of the topics discussed." | 1.27 | Preventive cardiology for coronary artery disease. ( Miller, WW, 1985) |
| "163 patients suffering from sudden hearing loss were examined with regard to their cardiovascular risk factors (hypertension, hyperlipaemia, cigarette smoking, hyperglycaemia, hyperuricaemia and obesity)." | 1.27 | [Etiology and pathogenesis of sudden deafness]. ( Friedrich, G, 1985) |
| "Type V hyperlipemia was often combined with other metabolic syndromes such as diabetes, hyperuricemia or gout, or obesity." | 1.26 | [Type V hyperlipemia. 54 cases (author's transl)]. ( Beaumont, V; Buxtorf, JC; Jacotot, B; Schlesinger, M, 1979) |
| "Analysis of 29 kindred showed hyperlipidemia in half of adult blood relatives; half of these had type III, the remainder usually had sample endogenous hyperglyceridemia (type IV)." | 1.25 | The biochemical, clinical, and genetic features of type III hyperlipoproteinemia. ( Fredrickson, DS; Levy, RI; Morganroth, J, 1975) |
| "the uric acid level was correlated to both the VLDL TG concentration and body weight independently." | 1.25 | Studies in asymptomatic primary hyperlipidaemia II. Clinical findings. ( Olsson, AG, 1975) |
| "Obesity was found in 19 per cent of all patients and serum uric acid levels over 0." | 1.25 | Myocardial infarction in young men. Study of risk factors in nine countries. ( Dolder, MA; Oliver, MF, 1975) |
| " The new method was compared with six other manual and mechanized methods for the dosage of uric acid, and the results were analyzed statistically." | 1.25 | [A mechanized enzymic method for the determination of uric acid (author's transl)]. ( Hunziker, P; Keller, H, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 228 (68.06) | 18.7374 |
| 1990's | 36 (10.75) | 18.2507 |
| 2000's | 39 (11.64) | 29.6817 |
| 2010's | 21 (6.27) | 24.3611 |
| 2020's | 11 (3.28) | 2.80 |
| Authors | Studies |
|---|---|
| Zhuang, H | 1 |
| Lin, Z | 1 |
| Zeng, S | 1 |
| Jiang, M | 1 |
| Chen, L | 1 |
| Jiang, X | 1 |
| Xu, Y | 2 |
| Hu, Y | 1 |
| Li, J | 2 |
| Yin, C | 1 |
| Xu, L | 1 |
| Li, S | 1 |
| Chen, Y | 2 |
| Wang, Y | 2 |
| Cheng, Z | 1 |
| Bai, Y | 1 |
| Palatini, P | 1 |
| Virdis, A | 1 |
| Masi, S | 1 |
| Mengozzi, A | 1 |
| Casiglia, E | 1 |
| Tikhonoff, V | 1 |
| Cicero, AFG | 1 |
| Ungar, A | 1 |
| Parati, G | 1 |
| Rivasi, G | 1 |
| Salvetti, M | 1 |
| Barbagallo, CM | 1 |
| Bombelli, M | 1 |
| Dell'Oro, R | 1 |
| Bruno, B | 1 |
| Lippa, L | 1 |
| D'Elia, L | 1 |
| Masulli, M | 1 |
| Verdecchia, P | 1 |
| Reboldi, G | 1 |
| Angeli, F | 1 |
| Mallamaci, F | 1 |
| Cirillo, M | 1 |
| Rattazzi, M | 1 |
| Cirillo, P | 1 |
| Gesualdo, L | 1 |
| Mazza, A | 1 |
| Giannattasio, C | 1 |
| Maloberti, A | 1 |
| Volpe, M | 1 |
| Tocci, G | 1 |
| Iaccarino, G | 1 |
| Nazzaro, P | 1 |
| Galletti, F | 1 |
| Ferri, C | 2 |
| Desideri, G | 1 |
| Viazzi, F | 1 |
| Pontremoli, R | 1 |
| Muiesan, ML | 1 |
| Grassi, G | 1 |
| Borghi, C | 1 |
| Wang, YY | 1 |
| Zhao, Q | 2 |
| Chen, B | 1 |
| Wang, N | 1 |
| Zhang, TJ | 1 |
| Jiang, YG | 1 |
| Wu, YL | 1 |
| He, N | 1 |
| Zhao, GM | 1 |
| Liu, X | 1 |
| Tan, MY | 1 |
| Mo, CY | 1 |
| Li, F | 1 |
| Stamp, LK | 1 |
| Chapman, P | 1 |
| Hudson, B | 1 |
| Frampton, C | 1 |
| Hamilton, G | 1 |
| Judd, A | 1 |
| Sotoudehmanesh, R | 1 |
| Tahmasbi, A | 1 |
| Sadeghi, A | 1 |
| Hosseini, H | 1 |
| Mohamadnejad, M | 1 |
| Eom, KS | 1 |
| Lee, YJ | 1 |
| Seo, HW | 1 |
| Kang, JY | 1 |
| Shim, JS | 1 |
| Lee, SH | 1 |
| Kuwabara, Y | 1 |
| Yasuno, S | 1 |
| Kasahara, M | 1 |
| Ueshima, K | 1 |
| Nakao, K | 1 |
| Chen, J | 2 |
| Wang, J | 1 |
| Zeng, D | 1 |
| Zhang, Y | 1 |
| Wu, M | 1 |
| Zhang, D | 1 |
| Hong, X | 1 |
| Abe, T | 1 |
| Yamamoto, S | 1 |
| Konishi, T | 1 |
| Takahashi, Y | 1 |
| Oishi, K | 1 |
| Fang, YJ | 1 |
| Wu, TY | 1 |
| Lin, CL | 1 |
| Su, CY | 1 |
| Li, JR | 1 |
| Chung, YL | 1 |
| Tien, N | 1 |
| Lim, YP | 1 |
| Sandoval-Plata, G | 1 |
| Nakafero, G | 1 |
| Chakravorty, M | 1 |
| Morgan, K | 1 |
| Abhishek, A | 1 |
| Thottam, GE | 1 |
| Krasnokutsky, S | 1 |
| Pillinger, MH | 1 |
| Salazar-Lugo, R | 1 |
| Barahona, A | 1 |
| Ortiz, K | 1 |
| Chtivez, C | 1 |
| Freire, P | 1 |
| Mndez, J | 1 |
| Bermeo, B | 1 |
| Santamaria, M | 1 |
| Salas, H | 1 |
| Abu-Ghanem, Y | 1 |
| Shvero, A | 1 |
| Kleinmann, N | 1 |
| Winkler, HZ | 1 |
| Zilberman, DE | 1 |
| Csont, T | 1 |
| Sárközy, M | 1 |
| Szűcs, G | 1 |
| Szűcs, C | 1 |
| Bárkányi, J | 1 |
| Bencsik, P | 1 |
| Gáspár, R | 1 |
| Földesi, I | 1 |
| Csonka, C | 1 |
| Kónya, C | 1 |
| Ferdinandy, P | 1 |
| Kose, E | 1 |
| An, T | 1 |
| Kikkawa, A | 1 |
| Matsumoto, Y | 1 |
| Hayashi, H | 1 |
| Liu, PJ | 1 |
| Ma, F | 1 |
| Lou, HP | 1 |
| Zhu, YN | 1 |
| Chen, JH | 2 |
| Wen, CP | 1 |
| Wu, SB | 1 |
| Lan, JL | 1 |
| Tsai, MK | 1 |
| Tai, YP | 1 |
| Lee, JH | 1 |
| Hsu, CC | 2 |
| Tsao, CK | 1 |
| Wai, JP | 1 |
| Chiang, PH | 1 |
| Pan, WH | 3 |
| Hsiung, CA | 1 |
| Dai, XM | 1 |
| Wei, L | 1 |
| Ma, LL | 1 |
| Chen, HY | 1 |
| Zhang, ZJ | 1 |
| Ji, ZF | 1 |
| Wu, WL | 1 |
| Ma, LY | 1 |
| Kong, XF | 1 |
| Jiang, LD | 1 |
| Sertoglu, E | 1 |
| Su, P | 1 |
| Hong, L | 1 |
| Zhao, Y | 1 |
| Sun, H | 1 |
| Li, L | 1 |
| Rozza, F | 1 |
| Trimarco, V | 1 |
| Izzo, R | 1 |
| Grassi, D | 1 |
| Su, BY | 1 |
| Tian, CF | 1 |
| Gao, BL | 1 |
| Tong, YH | 1 |
| Zhao, XH | 1 |
| Zheng, Y | 1 |
| Zhou, Z | 1 |
| Song, K | 1 |
| Qiu, J | 1 |
| Liu, C | 1 |
| Zhou, H | 1 |
| Guo, Z | 1 |
| Zhang, B | 1 |
| Dong, C | 1 |
| Mitsuhashi, H | 1 |
| Yatsuya, H | 1 |
| Matsushita, K | 1 |
| Zhang, H | 1 |
| Otsuka, R | 1 |
| Muramatsu, T | 1 |
| Takefuji, S | 1 |
| Hotta, Y | 1 |
| Kondo, T | 2 |
| Murohara, T | 1 |
| Toyoshima, H | 1 |
| Tamakoshi, K | 1 |
| Cífková, R | 1 |
| Nilsson, PM | 1 |
| Saitoh, S | 1 |
| Li, LJ | 1 |
| Chen, H | 1 |
| Ren, JY | 1 |
| Wang, L | 1 |
| Luo, Y | 1 |
| Lippi, G | 1 |
| Montagnana, M | 1 |
| Luca Salvagno, G | 1 |
| Targher, G | 2 |
| Cesare Guidi, G | 1 |
| Olivero, JJ | 2 |
| Nguyen, PT | 1 |
| Alonso-Martin, S | 1 |
| Nowakowski, A | 1 |
| Larrucea, S | 1 |
| Fernández, D | 1 |
| Vilar-Egea, M | 1 |
| Ayuso, MS | 1 |
| Parrilla, R | 1 |
| Becker, MA | 1 |
| Schumacher, HR | 1 |
| Espinoza, LR | 1 |
| Wells, AF | 1 |
| MacDonald, P | 1 |
| Lloyd, E | 1 |
| Lademacher, C | 1 |
| Teng, F | 1 |
| Zhu, R | 1 |
| Zou, C | 1 |
| Xue, Y | 1 |
| Yang, M | 1 |
| Song, H | 1 |
| Liang, J | 1 |
| Yeh, WT | 1 |
| Chuang, SY | 1 |
| Wu, YY | 1 |
| Attia, AM | 1 |
| El-Banna, SG | 1 |
| Nomeir, FR | 1 |
| Abd El-Basser, MI | 1 |
| Damasceno, DC | 1 |
| Volpato, GT | 1 |
| de Mattos Paranhos Calderon, I | 1 |
| Cunha Rudge, MV | 1 |
| Bruckert, E | 1 |
| Giral, P | 1 |
| Ratziu, V | 1 |
| Poynard, T | 1 |
| Chapman, MJ | 1 |
| Opolon, P | 1 |
| Turpin, G | 1 |
| Elisaf, M | 3 |
| Xu, YJ | 1 |
| Wu, XQ | 1 |
| Liu, W | 1 |
| Lin, XH | 1 |
| Chen, JW | 1 |
| He, RQ | 1 |
| Hepburn, AL | 1 |
| Kaye, SA | 1 |
| Feher, MD | 1 |
| Hisatome, I | 2 |
| Ogino, K | 2 |
| Igawa, O | 2 |
| Shigemasa, C | 1 |
| Melenovsky, V | 1 |
| Stulc, T | 1 |
| Kozich, V | 1 |
| Grauova, B | 1 |
| Krijt, J | 1 |
| Wichterle, D | 1 |
| Haas, T | 1 |
| Malik, J | 1 |
| Hradec, J | 1 |
| Ceska, R | 1 |
| Kayacan, SM | 1 |
| Kazancioğlu, R | 1 |
| Oflaz, H | 1 |
| Tuna, S | 1 |
| Milionis, HJ | 5 |
| Papakostas, J | 1 |
| Kakafika, A | 1 |
| Chasiotis, G | 1 |
| Seferiadis, K | 2 |
| Elisaf, MS | 6 |
| FELDMAN, EB | 3 |
| WALLACE, SL | 1 |
| BERKOWITZ, D | 2 |
| TRAVIA, L | 1 |
| DODINVAL, P | 1 |
| AMMANN, F | 1 |
| KLEIN, D | 1 |
| MACH, R | 1 |
| BOURSIER, B | 1 |
| Athyros, VG | 2 |
| Papageorgiou, AA | 1 |
| Symeonidis, AN | 1 |
| Pehlivanidis, AN | 1 |
| Bouloukos, VI | 1 |
| Mikhailidis, DP | 1 |
| Kakafika, AI | 1 |
| Tsouli, SG | 1 |
| Bairaktari, ET | 3 |
| Seferiadis, KI | 1 |
| Lin, JD | 2 |
| Chiou, WK | 1 |
| Weng, HF | 1 |
| Fang, JT | 1 |
| Liu, TH | 1 |
| Noguchi, Y | 1 |
| Tatsuno, I | 1 |
| Suyama, K | 1 |
| Shibata, T | 1 |
| Yoshida, T | 1 |
| Otsuka, Y | 1 |
| Fuse, M | 1 |
| Takeo, C | 1 |
| Saito, Y | 1 |
| Lin, CC | 1 |
| Yin, MC | 1 |
| Lin, MP | 1 |
| Liberopoulos, E | 2 |
| Goudevenos, J | 1 |
| Yanardag, R | 1 |
| Peksel, A | 1 |
| Yesilyaprak, B | 1 |
| Doger, MM | 1 |
| Arisan-Atac, I | 1 |
| Carlson, LA | 2 |
| Josephine, A | 1 |
| Veena, CK | 1 |
| Amudha, G | 1 |
| Preetha, SP | 1 |
| Varalakshmi, P | 1 |
| Maliavskaia, SI | 1 |
| Lebedev, AV | 1 |
| Ternovskaia, VA | 1 |
| Boĭko, ER | 1 |
| Ovechkin, AO | 1 |
| Kaneva, AM | 1 |
| Potolitsyna, NN | 1 |
| Boĭko, SG | 1 |
| Gebbie, T | 1 |
| Prior, IA | 1 |
| Steinmetz, J | 1 |
| Morin, C | 1 |
| Panek, E | 1 |
| Siest, G | 1 |
| Drouin, P | 1 |
| Ambrosch, P | 1 |
| Neuberger, M | 1 |
| Roche, S | 1 |
| Moinade, S | 1 |
| Scherhag, R | 1 |
| Bayliss, R | 1 |
| Clarke, C | 1 |
| Whitehead, TP | 1 |
| Whitfield, AG | 1 |
| Yu, TF | 1 |
| Laskarzewski, PM | 1 |
| Khoury, P | 2 |
| Morrison, JA | 2 |
| Kelly, K | 1 |
| Glueck, CJ | 3 |
| Keller, U | 1 |
| Staub, JJ | 1 |
| Hauenstein, M | 1 |
| Müller, J | 1 |
| Gimeno, A | 1 |
| Zaragozá, E | 1 |
| Riva, C | 1 |
| Ortín, A | 1 |
| Díaz Ortuño, A | 1 |
| Leiva, C | 1 |
| Díaz Calderón, E | 1 |
| Lithell, H | 1 |
| Vessby, B | 1 |
| Boberg, J | 1 |
| Hellsing, K | 1 |
| Rafnsson, V | 1 |
| Bengtsson, C | 1 |
| Schneider, H | 2 |
| Ziegelasch, HJ | 1 |
| Adamska-Dyniewska, H | 1 |
| Bała, T | 1 |
| Florczak, H | 1 |
| Trojanowska, B | 1 |
| Trzcinka, M | 1 |
| Darlington, LG | 2 |
| Slack, J | 2 |
| Scott, JT | 3 |
| Laskarzewski, P | 1 |
| Kelly, KA | 1 |
| Mellies, MJ | 1 |
| Tillett, S | 1 |
| Reinhardt, K | 1 |
| Yamazaki, K | 1 |
| Murata, M | 1 |
| Akaoka, Y | 1 |
| Yamanouchi, T | 1 |
| Gresser, U | 1 |
| Gathof, BS | 1 |
| Gross, M | 1 |
| Tinahones, FJ | 4 |
| Soriguer, FJ | 2 |
| Collantes, E | 4 |
| Pérez-Lindón, G | 1 |
| Sánchez Guijo, P | 3 |
| Lillo, JA | 1 |
| Lal, SM | 1 |
| Hewett, JE | 1 |
| Petroski, GF | 1 |
| Van Stone, JC | 1 |
| Ross, G | 1 |
| Klarica, J | 1 |
| Grahovac, B | 1 |
| Kono, S | 1 |
| Shinchi, K | 1 |
| Imanishi, K | 1 |
| Honjo, S | 1 |
| Todoroki, I | 1 |
| Cisnal, A | 1 |
| Añon, J | 1 |
| Sanchez-Guijo, P | 1 |
| Bergstrand, L | 1 |
| Zavaroni, I | 1 |
| Mazza, S | 1 |
| Fantuzzi, M | 1 |
| Dall'Aglio, E | 1 |
| Bonora, E | 2 |
| Delsignore, R | 1 |
| Passeri, M | 1 |
| Reaven, GM | 2 |
| Nishioka, K | 1 |
| Iwatani, M | 3 |
| Chen, CY | 1 |
| Chen, CS | 1 |
| Schmidt, MI | 1 |
| Watson, RL | 1 |
| Duncan, BB | 1 |
| Metcalf, P | 1 |
| Brancati, FL | 1 |
| Sharrett, AR | 1 |
| Davis, CE | 1 |
| Heiss, G | 1 |
| Crepaldi, G | 2 |
| Manzato, E | 1 |
| Itoh, T | 1 |
| Horie, S | 1 |
| Takahashi, K | 1 |
| Okubo, T | 1 |
| Wasada, T | 2 |
| Katsumori, K | 1 |
| Saeki, A | 1 |
| Tsutsumi, Z | 1 |
| Yamamoto, T | 2 |
| Takahashi, S | 1 |
| Moriwaki, Y | 1 |
| Higashino, K | 1 |
| Bai, CH | 1 |
| Chen, JR | 1 |
| Chiu, HC | 1 |
| C-Soriguer, FJ | 1 |
| González-Ruiz, A | 1 |
| Ruano, TJ | 1 |
| Pareja, A | 1 |
| Takeda, M | 1 |
| Noto, M | 1 |
| Tofuku, Y | 1 |
| Madianov, IV | 1 |
| Balabolkin, MI | 1 |
| Saperov, VN | 1 |
| Markov, DS | 1 |
| Oreshnikov, EV | 1 |
| Grigor'ev, AA | 1 |
| Markova, TN | 1 |
| Donahue, RP | 1 |
| Bean, JA | 1 |
| Donahue, RD | 1 |
| Goldberg, RB | 1 |
| Prineas, RJ | 1 |
| Yoneda, T | 1 |
| Kawakami, H | 1 |
| Kita, A | 1 |
| Tagashira, S | 1 |
| Matsuura, M | 1 |
| Matsuoka, Y | 1 |
| Vazquez, F | 1 |
| Kiechl, S | 1 |
| Willeit, J | 1 |
| Oberhollenzer, F | 1 |
| Egger, G | 1 |
| Alberiche, M | 1 |
| Bonadonna, RC | 1 |
| Muggeo, M | 1 |
| Wannamethee, SG | 2 |
| Donskov, AS | 1 |
| Balkarov, IM | 1 |
| Fadina, ZM | 1 |
| Golub', GV | 1 |
| Anikina, SA | 1 |
| Saltykova, NG | 1 |
| Goncharov, VS | 1 |
| Feofanova, ID | 1 |
| Liamis, G | 1 |
| Barden, AE | 1 |
| Beilin, LJ | 1 |
| Ritchie, J | 1 |
| Walters, BN | 1 |
| Michael, C | 1 |
| Pitkänen, OM | 1 |
| Vanhanen, H | 1 |
| Pitkänen, E | 1 |
| Iwamoto, Y | 1 |
| Kamatani, N | 2 |
| Garg, A | 1 |
| Stiefel, P | 1 |
| Montilla, C | 1 |
| García-Morillo, S | 1 |
| Pamies, E | 1 |
| Miranda, ML | 1 |
| Villar, J | 1 |
| Sun, JH | 1 |
| See, LC | 1 |
| Hsu, WC | 1 |
| Tsai, JS | 1 |
| Håglin, L | 1 |
| Jenkins, DJ | 1 |
| Kendall, CW | 1 |
| Vidgen, E | 1 |
| Augustin, LS | 1 |
| van Erk, M | 1 |
| Geelen, A | 1 |
| Parker, T | 1 |
| Faulkner, D | 1 |
| Vuksan, V | 1 |
| Josse, RG | 1 |
| Leiter, LA | 1 |
| Connelly, PW | 1 |
| Chen, SY | 1 |
| Chen, CL | 1 |
| Shen, ML | 1 |
| Hosoya, T | 1 |
| Kiortsis, DN | 1 |
| Achimastos, A | 1 |
| Nikas, S | 1 |
| Bairaktari, E | 1 |
| Miltiadous, G | 1 |
| Tsimihodimos, V | 1 |
| Ladenson, JH | 1 |
| Ryan, JR | 1 |
| Nishida, Y | 1 |
| Akaoka, I | 1 |
| Nishizawa, T | 1 |
| Maruki, M | 1 |
| Maruki, K | 1 |
| Henninces, D | 1 |
| Anisimov, VE | 1 |
| Morganroth, J | 1 |
| Levy, RI | 2 |
| Fredrickson, DS | 1 |
| Olsson, AG | 2 |
| Mertz, DP | 9 |
| Hohneck, A | 1 |
| Dujovne, CA | 1 |
| Azarnoff, DL | 1 |
| Huffman, DH | 1 |
| Pentikäinen, P | 1 |
| Hurwitz, A | 1 |
| Shoeman, DW | 1 |
| Zöller, H | 1 |
| Gross, W | 1 |
| Ditzel, J | 1 |
| Bang, HO | 1 |
| Loizzi, P | 1 |
| Terlizzi, N | 1 |
| Pfahl, F | 1 |
| Rouffy, J | 1 |
| Puissant, A | 1 |
| Duperrat, B | 1 |
| Sailer, S | 1 |
| Greenberg, BH | 1 |
| Blackwelder, WC | 1 |
| Watanabe, Y | 1 |
| Ito, T | 1 |
| Hempel, RD | 1 |
| Müller, G | 2 |
| Burchardt, U | 1 |
| Hjermann, I | 1 |
| Enger, SC | 1 |
| Helgeland, A | 1 |
| Holme, I | 1 |
| Leren, P | 1 |
| Trygg, K | 1 |
| Gianoulakis, C | 1 |
| Lis, M | 1 |
| Davignon, J | 2 |
| Chrétien, M | 1 |
| Schlesinger, M | 1 |
| Jacotot, B | 1 |
| Beaumont, V | 1 |
| Buxtorf, JC | 1 |
| Krut, LH | 1 |
| Seftel, HC | 1 |
| Joffe, BI | 1 |
| Bassett, DR | 1 |
| Mikkelsen, WM | 1 |
| Buckingham, RB | 1 |
| Block, WD | 1 |
| Sidiq, M | 1 |
| Shakibai, A | 1 |
| DiGaetano, R | 1 |
| Liou, LL | 1 |
| Lynch, RE | 1 |
| Kjellstrand, CM | 1 |
| Coccia, PF | 1 |
| Heidelmann, G | 5 |
| Thiele, P | 3 |
| Malmendier, CL | 1 |
| van den Bergen, CJ | 1 |
| Emplit, G | 1 |
| Delcroix, C | 1 |
| Schettler, G | 1 |
| Geisenhainer, G | 1 |
| Julich, H | 1 |
| Triebe, G | 1 |
| Emmerson, BT | 3 |
| Lofland, HB | 1 |
| Clarkson, TB | 1 |
| Buhr, J | 1 |
| Schütz, J | 1 |
| Gibson, T | 3 |
| Kilbourn, K | 1 |
| Horner, I | 1 |
| Simmonds, HA | 1 |
| Arntz, HR | 1 |
| Dreykluft, HR | 1 |
| Leonhardt, H | 1 |
| Opherk, D | 1 |
| Scola, R | 1 |
| Morgenstern, W | 1 |
| Stockmann, G | 1 |
| Nüssel, E | 2 |
| Kübler, W | 1 |
| Neuman, J | 2 |
| de Neumann, MP | 1 |
| Valero, E | 2 |
| Lindental, D | 1 |
| Pistautz, H | 1 |
| Streicher, E | 1 |
| Hachmann, H | 1 |
| Chmiel, H | 1 |
| von Mylius, U | 1 |
| Höpker, WW | 1 |
| Pasternak, G | 1 |
| Heyden, S | 2 |
| Berchtold, P | 1 |
| Berger, M | 1 |
| Gries, FA | 1 |
| Zimmermann, H | 1 |
| Puhl, W | 2 |
| Niethard, FU | 2 |
| Hamacher, P | 1 |
| Augustin, J | 2 |
| Greten, H | 3 |
| Matzkies, F | 4 |
| Schulzky, D | 1 |
| Berg, G | 4 |
| Klein, S | 1 |
| Marré, E | 1 |
| Koza, KD | 1 |
| Bueno, F | 1 |
| Mezey, E | 1 |
| Krízek, V | 1 |
| Chodorowski, Z | 1 |
| Keller, C | 2 |
| Wolfram, G | 2 |
| Zöllner, N | 2 |
| Blanc, JJ | 2 |
| Boschat, J | 2 |
| Morin, JF | 1 |
| Granatelli, D | 2 |
| Floch, H | 1 |
| Penther, P | 2 |
| Laurens, P | 1 |
| Gavelle, P | 1 |
| Maurice, P | 1 |
| Válek, J | 1 |
| Grafnetter, D | 1 |
| Slabochová, Z | 1 |
| Pechar, J | 1 |
| Frank, O | 4 |
| Kolenda, KD | 1 |
| Copti, MC | 1 |
| Lefebvre D'amour, M | 1 |
| Bissoon Doyal, D | 1 |
| Hillemand, B | 1 |
| Joly, JP | 1 |
| Membrey-Maheo, E | 1 |
| Ouvry, D | 1 |
| Rössner, S | 1 |
| Walldius, G | 1 |
| Lang, PD | 1 |
| Wilke, H | 3 |
| Grossgerge, H | 1 |
| Haubold, E | 1 |
| Kahlke, W | 1 |
| Frahm, H | 3 |
| Regler, B | 1 |
| Wexler, BC | 1 |
| Greenberg, BP | 1 |
| Seige, K | 1 |
| Rakow, AD | 1 |
| Klor, HU | 2 |
| Kuter, E | 1 |
| Ditschuneit, HH | 1 |
| Ditschuneit, H | 2 |
| Elkeles, RS | 1 |
| Berndt, G | 1 |
| Brooks, PM | 1 |
| Germa, D | 1 |
| Ewald, W | 1 |
| Klose, G | 1 |
| Koderisch, HO | 1 |
| Klemens, UH | 1 |
| von Löwis of Menar, P | 1 |
| Ravenscroft, PJ | 1 |
| Stanhope, JM | 1 |
| Malcolm, JB | 1 |
| Synková, J | 1 |
| Krupar, V | 1 |
| Brátová, M | 1 |
| Groh, J | 1 |
| Dítĕ, P | 1 |
| Bokelund, H | 1 |
| Müller-Jensen, A | 2 |
| Eickhoff, W | 1 |
| Hellner, KA | 2 |
| Dolder, MA | 1 |
| Oliver, MF | 1 |
| Lequesne, M | 1 |
| Bensasson, M | 1 |
| Kahn, MF | 1 |
| de Sèze, S | 2 |
| Hobbie, RK | 1 |
| Reece, RL | 1 |
| MacRae, AR | 1 |
| Macdonald, I | 1 |
| Hunziker, P | 1 |
| Keller, H | 1 |
| Gautier, JC | 1 |
| Morelot, D | 1 |
| Mantero, O | 1 |
| Conti, F | 1 |
| Biasi, G | 2 |
| Sirtori, R | 1 |
| Seely, S | 1 |
| Siegenthaler-Zuber, G | 1 |
| Collantes Estevéz, E | 2 |
| Tinahones Madueño, FJ | 1 |
| González Ruiz, A | 1 |
| Añón Barbudo, J | 2 |
| Pineda Priego, M | 2 |
| Prichard, BN | 1 |
| Owens, CW | 1 |
| Woolf, AS | 1 |
| Küng, EE | 1 |
| Glauser, T | 1 |
| Härter, G | 1 |
| Klimm, HD | 1 |
| König, B | 1 |
| Koberstein, R | 1 |
| Lieber, CS | 2 |
| Czajkowski, J | 1 |
| Jazdzewski, B | 1 |
| Pińkowski, R | 1 |
| Kullich, W | 1 |
| Ulreich, A | 1 |
| Klein, G | 1 |
| Pronicka, E | 1 |
| Rowińska, E | 1 |
| Miłoszewska, E | 1 |
| Delli Gatti, I | 1 |
| La Corte, R | 1 |
| Bertelli, R | 1 |
| Gilli, G | 1 |
| Menozzi, L | 1 |
| Field, MJ | 1 |
| Lawrence, JR | 1 |
| Hyams, DE | 1 |
| Mesquita, MF | 1 |
| Seabra, MP | 1 |
| Halpern, MJ | 4 |
| Miller, WW | 1 |
| Darrelmann, O | 1 |
| Kreissig, I | 1 |
| Richard, G | 1 |
| Friedrich, G | 1 |
| Fox, IH | 1 |
| John, D | 1 |
| DeBruyne, S | 1 |
| Dwosh, I | 1 |
| Marliss, EB | 1 |
| Miguel, MJ | 1 |
| Jensen, J | 1 |
| Blankenhorn, DH | 1 |
| Kornerup, V | 1 |
| Felt, V | 1 |
| Stárka, L | 1 |
| Hanefeld, M | 2 |
| Schulze, J | 1 |
| Fritz, T | 1 |
| Kemmer, C | 1 |
| Carmena, R | 1 |
| Aronow, WS | 1 |
| Vangrow, JS | 1 |
| Nelson, WH | 1 |
| Pagano, J | 1 |
| Papageorge's, NP | 1 |
| Khursheed, M | 1 |
| Harding, PR | 1 |
| Khemka, M | 1 |
| Schosinsky, KH | 1 |
| Lehmann, HP | 1 |
| Beeler, MF | 1 |
| Zsernaviczky, J | 1 |
| von Torklus, D | 2 |
| Voigt, KD | 1 |
| Apostolakis, M | 1 |
| Jungmann, H | 1 |
| Sinclair, HM | 1 |
| de Gennes, JL | 2 |
| Thomopoulos, P | 1 |
| Truffert, J | 1 |
| Labrousse de Tregomain, B | 1 |
| Newcombe, DS | 1 |
| Wilson, WS | 1 |
| Hulley, SB | 1 |
| Burrows, MI | 1 |
| Nichaman, MZ | 1 |
| Rose, HG | 1 |
| Kranz, P | 1 |
| Weinstock, M | 1 |
| Juliano, J | 1 |
| Haft, JI | 1 |
| Hazzard, WR | 2 |
| Goldstein, JL | 2 |
| Schrott, MG | 1 |
| Motulsky, AG | 2 |
| Bierman, EL | 2 |
| Eisenberg, S | 1 |
| Kwiterovich, PO | 1 |
| Margolis, S | 1 |
| Lewis, B | 3 |
| Chait, A | 2 |
| Oakley, CM | 1 |
| Wootton, ID | 1 |
| Krikler, DM | 1 |
| Onitiri, A | 1 |
| Sigurdsson, G | 1 |
| February, A | 1 |
| Bertrand, E | 1 |
| Baudin, L | 1 |
| Chauvet, J | 1 |
| Assamoi, MO | 1 |
| Beda, B | 1 |
| Renambot, J | 1 |
| Thomas, JY | 1 |
| Le Bras, M | 1 |
| de Neuman, MP | 1 |
| Talmasky, S | 1 |
| Pesce, R | 1 |
| Martiarena, JL | 1 |
| Grahame, R | 3 |
| Pérez Cano, R | 1 |
| Yánez Polo, MA | 1 |
| Melero Bellido, M | 1 |
| Casimiro Soringuer, F | 1 |
| Causse Prado, M | 1 |
| Muñóz González, J | 1 |
| Aigner, O | 1 |
| Schlick, W | 1 |
| Sirtori, CR | 2 |
| Vercellio, G | 1 |
| Agradi, E | 2 |
| Malan, E | 1 |
| Brunner, C | 1 |
| Emmrich, R | 1 |
| Gluck, FB | 1 |
| Carter, AC | 2 |
| Diamond, HS | 1 |
| Wellmann, KF | 1 |
| Volk, BW | 1 |
| Engel, HJ | 1 |
| Page, HL | 1 |
| Campbell, WB | 1 |
| Blacket, RB | 2 |
| Leelarthaepin, B | 2 |
| Palmer, AJ | 2 |
| Woodhill, JM | 1 |
| Tidl, G | 1 |
| Barrow, MV | 1 |
| Ramsey, HW | 1 |
| Stamler, J | 1 |
| Walton, KW | 1 |
| Craig, GM | 1 |
| Prior, P | 1 |
| Waterhouse, JA | 1 |
| Skilton, J | 1 |
| Schwandt, P | 1 |
| Kilani, C | 1 |
| Zoppi, S | 1 |
| Quarisa, B | 1 |
| Schneider, V | 2 |
| Roux, H | 2 |
| Vovan, L | 2 |
| Dutertre, P | 2 |
| Serratrice, G | 2 |
| Recordier, AM | 2 |
| Bachmann, K | 1 |
| Bergner, D | 1 |
| Grabner, W | 1 |
| Bornhofen, E | 1 |
| Stürzenhofecker, P | 1 |
| Sailer, D | 1 |
| Märtens, HR | 1 |
| van Eimeren, W | 1 |
| Härich, B | 1 |
| Fischer, V | 1 |
| Dietschi, C | 1 |
| Babucke, G | 1 |
| Wollenweber, J | 2 |
| Christl, HL | 1 |
| Schlierf, C | 1 |
| Wohlenberg, H | 1 |
| Bluhm, GB | 1 |
| Riddle, JM | 1 |
| Schrott, HG | 1 |
| Irsigler, K | 1 |
| Flegel, U | 1 |
| Kühn, P | 1 |
| Schubert, H | 1 |
| Iván, E | 1 |
| Biro, L | 1 |
| Székely, L | 1 |
| Haller, H | 1 |
| Leonhardt, W | 1 |
| Moser, W | 1 |
| Leiber, B | 1 |
| Olbrich, G | 1 |
| Pereira-Miguel, MJ | 1 |
| Bennett, RM | 1 |
| Gligore, V | 1 |
| Hincu, N | 1 |
| Tecuceanu, R | 1 |
| Sopon, E | 1 |
| Hoinărescu, E | 1 |
| Cristea, A | 1 |
| Pereira Miguel, MS | 1 |
| Gibson, TJ | 1 |
| Borrie, P | 2 |
| Amer, M | 1 |
| el-Shazly, M | 1 |
| Blétry, O | 1 |
| Cartier, P | 1 |
| Hamet, M | 1 |
| Clauvel, JP | 1 |
| Zsernaviezky, J | 1 |
| Kuntz, D | 1 |
| Rouques, C | 1 |
| Paolaggi, F | 1 |
| Ryckewaert, A | 1 |
| Harvengt, C | 1 |
| Lavenne, F | 1 |
| Moinuddin, M | 1 |
| Witter, RF | 1 |
| Quist, KD | 1 |
| Watt, EW | 1 |
| Gahagan, HE | 1 |
| Mendez, J | 1 |
| Diamond, H | 1 |
| Henninges, D | 4 |
| Schwoerer, P | 1 |
| Fessel, WJ | 1 |
| Thorpe, JJ | 1 |
| Daley, JM | 1 |
| Aubry, F | 1 |
| Noël, C | 1 |
| Lapierre, Y | 1 |
| Lafortune, M | 1 |
| Benedetti, A | 1 |
| Bucciante, G | 1 |
| Cattano, G | 1 |
| Nardini, A | 1 |
| Hayduk, K | 1 |
| Dürr, F | 1 |
| Schollmeyer, P | 1 |
| Drake, JW | 1 |
| Bradford, RH | 1 |
| McDearmon, M | 1 |
| Furman, RH | 1 |
| Khachadurian, A | 1 |
| Bechar, M | 1 |
| Kott, E | 1 |
| Bornstein, B | 1 |
| Kaltreider, HB | 1 |
| Talal, N | 1 |
| Cottet, J | 1 |
| Greene, ML | 1 |
| Fujimoto, WY | 1 |
| Seegmiller, JE | 1 |
| Nordoy, A | 1 |
| Gjone, E | 1 |
| Orö, L | 1 |
| Gärtner, A | 1 |
| Tellkamp, F | 1 |
| Sulzberger, I | 1 |
| Klöpfer, M | 1 |
| Doenecke, P | 1 |
| Hild, R | 1 |
| Nobbe, F | 1 |
| Schmidt, FH | 1 |
| Wagner, E | 1 |
| Zaar, I | 1 |
| Klöpfer-Zaar, M | 1 |
| Thieme, G | 1 |
| Scheier, CA | 1 |
| Jacobs, D | 1 |
| Bluestone, R | 1 |
| Mervart, I | 1 |
| Tremel, R | 1 |
| Pohl, W | 1 |
| Günther, R | 1 |
| Herbst, M | 1 |
| Knapp, E | 1 |
| Manzke, H | 1 |
| Barlow, KA | 1 |
| Khachadurian, AK | 1 |
| Bernheim, C | 1 |
| Strejcek, J | 1 |
| Kucerová, L | 1 |
| Holländer, E | 1 |
| Schwarczmann, P | 1 |
| Haim, S | 1 |
| Gellei, B | 1 |
| Better, OS | 1 |
| Barrillon, A | 1 |
| Binet, JP | 1 |
| Hazan, E | 1 |
| Lenègre, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Value of Uric Acid as Early Predictor of Lupus Nephritis in Assiut University Hospital[NCT05402735] | 100 participants (Anticipated) | Observational | 2022-06-15 | Recruiting | |||
| Novel Methods for Ascertainment of Gout Flares -A Pilot Study[NCT02855437] | 44 participants (Actual) | Interventional | 2016-09-30 | Completed | |||
| A Phase 3, Randomized, Multicenter, Double-Blind, Allopurinol-Controlled Study Assessing the Efficacy and Safety of Oral Febuxostat in Subjects With Gout.[NCT00430248] | Phase 3 | 2,269 participants (Actual) | Interventional | 2007-02-28 | Completed | ||
| Phase IV Study of Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia[NCT00595504] | Phase 4 | 25 participants (Actual) | Interventional | 2008-01-31 | Completed | ||
| Omentectomy for Treatment of Diabetes Mellitus Type 2[NCT00270439] | Phase 1 | 10 participants (Actual) | Interventional | 2006-01-31 | Completed | ||
| Phase 4 Study of the Effects of Pravastatin on Cholesterol Levels, Inflammation and Cognition in Schizophrenia[NCT01082588] | Phase 4 | 60 participants (Actual) | Interventional | 2010-06-30 | Completed | ||
| "Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial. Prospective, Double Blind, Randomized, Controlled Trial Comparing the Effects of Supplemental Zinc Sulfate and Placebo on the Severity of Rosacea."[NCT00395226] | 65 participants (Actual) | Interventional | 2006-07-31 | Terminated (stopped due to Difficulty recruiting subjects) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Feasibility ----Assessed by the percentage of participants completing answer IRV/RheumPRO queries. (NCT02855437)
Timeframe: 6 months
| Intervention | percentage of weekly response (Mean) |
|---|---|
| Interactive Voice Response | 81 |
| RheumPro Smartphone Application | 80 |
Percentage of total study population preferring IVR vs. RheumPRO (NCT02855437)
Timeframe: 6 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Interactive Voice Response | 3 |
| RheumPro Smartphone Application | 28 |
The percent change in serum urate from baseline to the Final visit was summarized. The final visit was the last visit at which a serum urate value was collected. (NCT00430248)
Timeframe: Baseline and Last Visit on treatment (up to 6 months)
| Intervention | percent change from baseline (Mean) |
|---|---|
| Febuxostat 40 mg QD | -33.1 |
| Febuxostat 80 mg QD | -40.6 |
| Allopurinol 200 mg or 300 mg QD | -31.3 |
Serum urate values were obtained at the Month 2 visit. The percent change in serum urate from baseline to the Month 2 visit was summarized. (NCT00430248)
Timeframe: Baseline and Month 2
| Intervention | percent change from baseline (Mean) |
|---|---|
| Febuxostat 40 mg QD | -35.1 |
| Febuxostat 80 mg QD | -44.5 |
| Allopurinol 200 mg or 300 mg QD | -33.8 |
Serum urate values were obtained at the Month 4 visit. The percent change in serum urate from baseline to the Month 4 visit was summarized. (NCT00430248)
Timeframe: Baseline and Month 4
| Intervention | percent change from baseline (Mean) |
|---|---|
| Febuxostat 40 mg QD | -34.9 |
| Febuxostat 80 mg QD | -45.5 |
| Allopurinol 200 mg or 300 mg QD | -34.5 |
Serum urate values were obtained at the Month 6 visit. The percent change in serum urate from baseline to the Month 6 visit was summarized. (NCT00430248)
Timeframe: Baseline and Month 6
| Intervention | percent change from baseline (Mean) |
|---|---|
| Febuxostat 40 mg QD | -35.6 |
| Febuxostat 80 mg QD | -45.1 |
| Allopurinol 200 mg or 300 mg QD | -34.4 |
The percentage of subjects with mild-to-moderate renal impairment whose serum urate was <6.0 mg/dL at the final visit was summarized. The final visit was the last visit at which a serum urate value was collected. (NCT00430248)
Timeframe: Last Visit on treatment (up to 6 months)
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 49.7 |
| Febuxostat 80 mg QD | 71.6 |
| Allopurinol 200 mg or 300 mg QD | 42.3 |
The percentage of subjects whose serum urate level was <6.0 mg/dL at the Final Visit was summarized. The Final Visit was the last visit at which a serum urate value was collected. (NCT00430248)
Timeframe: Last Visit on treatment (up to 6 months)
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 45.2 |
| Febuxostat 80 mg QD | 67.1 |
| Allopurinol 200 mg or 300 mg QD | 42.1 |
The percentage of subjects whose serum urate level was <4.0 mg/dL at the Final Visit was summarized. The Final Visit was the last visit at which a serum urate values was collected. (NCT00430248)
Timeframe: Last Visit on treatment (up to 6 months)
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 2.5 |
| Febuxostat 80 mg QD | 17.5 |
| Allopurinol 200 mg or 300 mg QD | 1.5 |
Serum urate values were obtained at the Month 2 visit. The percentage of subjects whose serum urate was <4.0 mg/dL at the Month 2 visit was summarized. (NCT00430248)
Timeframe: Month 2
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 2.1 |
| Febuxostat 80 mg QD | 17.5 |
| Allopurinol 200 mg or 300 mg QD | 1.5 |
Serum urate values were obtained at the Month 4 visit. The percentage of subjects whose serum urate was <4.0 mg/dL at the Month 4 visit was summarized. (NCT00430248)
Timeframe: Month 4
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 2.0 |
| Febuxostat 80 mg QD | 18.6 |
| Allopurinol 200 mg or 300 mg QD | 1.4 |
Serum urate values were obtained at the Month 6 visit. The percentage of subjects whose serum urate was <4.0 mg/dL at the Month 6 visit was summarized. (NCT00430248)
Timeframe: Month 6
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 3.1 |
| Febuxostat 80 mg QD | 20.3 |
| Allopurinol 200 mg or 300 mg QD | 1.8 |
The percentage of subjects whose serum urate level was <5.0 mg/dL at the Final Visit was summarized. The Final Visit was the last visit at which a serum urate values was collected. (NCT00430248)
Timeframe: Last Visit on treatment (up to 6 months)
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 16.5 |
| Febuxostat 80 mg QD | 44.0 |
| Allopurinol 200 mg or 300 mg QD | 13.2 |
Serum urate values were obtained at the Month 2 visit. The percentage of subjects whose serum urate was <5.0 mg/dL at the Month 2 visit was summarized. (NCT00430248)
Timeframe: Month 2
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 15.4 |
| Febuxostat 80 mg QD | 45.9 |
| Allopurinol 200 mg or 300 mg QD | 11.7 |
Serum urate values were obtained at the Month 4 visit. The percentage of subjects whose serum urate was <5.0 mg/dL at the Month 4 visit was summarized. (NCT00430248)
Timeframe: Month 4
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 15.0 |
| Febuxostat 80 mg QD | 51.6 |
| Allopurinol 200 mg or 300 mg QD | 13.5 |
Serum urate values were obtained at the Month 6 visit. The percentage of subjects whose serum urate was <5.0 mg/dL at the Month 6 visit was summarized. (NCT00430248)
Timeframe: Month 6
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 19.3 |
| Febuxostat 80 mg QD | 49.7 |
| Allopurinol 200 mg or 300 mg QD | 14.8 |
Serum urate values were obtained at the Month 2 visit. The percentage of subjects whose serum urate was <6.0 mg/dL at the Month 2 visit was summarized. (NCT00430248)
Timeframe: Month 2
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 49.1 |
| Febuxostat 80 mg QD | 74.1 |
| Allopurinol 200 mg or 300 mg QD | 43.2 |
Serum urate values were obtained at the Month 4 visit. The percentage of subjects whose serum urate was <6.0 mg/dL at the Month 4 visit was summarized. (NCT00430248)
Timeframe: Month 4
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 47.1 |
| Febuxostat 80 mg QD | 75.2 |
| Allopurinol 200 mg or 300 mg QD | 45.5 |
Serum urate values were obtained at the Month 6 visit. The percentage of subjects whose serum urate was <6.0 mg/dL at the Month 6 visit was summarized. (NCT00430248)
Timeframe: Month 6
| Intervention | percentage of participants (Number) |
|---|---|
| Febuxostat 40 mg QD | 48.9 |
| Febuxostat 80 mg QD | 75.3 |
| Allopurinol 200 mg or 300 mg QD | 46.6 |
A comparison between the ramelteon group and the placebo group of change in abdominal fat measured by a DEXA scan, assessed at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | g (Mean) |
|---|---|
| Ramelteon | 3934.86 |
| Placebo (Sugar Pill) | 5120.92 |
A comparison between the ramelteon group and the placebo group of change in insulin resistance measured by the homeostatic model assessment of insulin resistance (HOMA-IR), assessed at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | HOMA score (Mean) |
|---|---|
| Ramelteon | 2.4 |
| Placebo (Sugar Pill) | 2.36 |
A comparison between the ramelteon group and the placebo group in change in waist circumference (measured in cm) measured at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | cm (Mean) |
|---|---|
| Ramelteon | 106.09 |
| Placebo (Sugar Pill) | 108.37 |
(NCT01082588)
Timeframe: Baseline, week 12
| Intervention | mg/L (Mean) |
|---|---|
| Pravastatin | 0.8063 |
| Placebo | -0.5136 |
(NCT01082588)
Timeframe: Baseline, week 12
| Intervention | mg/dl (Mean) |
|---|---|
| Pravastatin | -25.565 |
| Placebo | -2.913 |
"The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery measures cognitive functioning within 7 domains: speed of processing, attention/vigilance, working memory (non verbal and verbal), verbal learning, visual learning, reasoning and problem solving and social cognition.~The composite score is calculated by the MATRICS computer program, which equally weights each of the 7 domain scores. The range of composite scores is 20-80. Higher scores indicate higher levels or cognitive functioning, while lower scores indicate lower levels of cognitive functioning." (NCT01082588)
Timeframe: Baseline, week 12
| Intervention | Scores on a scale (Mean) |
|---|---|
| Pravastatin | 4.0417 |
| Placebo | 4.125 |
This is a subscale of the Positive and Negative Syndrome Scale (PANSS). The range for this subscale is 15-105. All items are summed to calculate the total score. Better outcomes have lower numbers and worse outcomes have higher numbers. (NCT01082588)
Timeframe: Baseline, week 12
| Intervention | Scores on a scale (Mean) |
|---|---|
| Pravastatin | -5.625 |
| Placebo | -3.76 |
This is a subscale of the Positive and Negative Syndrome Scale (PANSS). The range for this subscale is 7-49. All items are summed to calculate the total score. Better outcomes have lower numbers and worse outcomes have higher numbers. (NCT01082588)
Timeframe: Baseline, week 12
| Intervention | Scores on a scale (Mean) |
|---|---|
| Pravastatin | -0.83 |
| Placebo | -0.28 |
This is a subscale of the Positive and Negative Syndrome Scale (PANSS). The range for this subscale is 7-49. All items are summed to calculate the total score. Better outcomes have lower numbers and worse outcomes have higher numbers. (NCT01082588)
Timeframe: Baseline, week 12
| Intervention | Scores on a scale (Mean) |
|---|---|
| Pravastatin | -2.9583 |
| Placebo | -2.44 |
The Positive and Negative Syndrome Scale (PANSS) is a scale used to rate severity of schizophrenia. All items are summed to calculate the total score. The scale range is 30-210. Better outcomes have lower numbers and worse outcomes have higher numbers. (NCT01082588)
Timeframe: Baseline, week 12
| Intervention | Scores on a scale (Mean) |
|---|---|
| Pravastatin | -9.416 |
| Placebo | -6.48 |
Modified Rosacea Severity Scoring System evaluating four signs of rosacea, flushing (transient erythema or redness), erythema (redness), papules and pustules and telangiectasia (spider-veins) ranges from 0 (best, absent) to 12 (worst, severe on all items) (NCT00395226)
Timeframe: 90 days
| Intervention | units on scale 0 to 12 (Mean) |
|---|---|
| Placebo (Lactose) | 4.9 |
| Zinc Sulfate | 5.1 |
38 reviews available for uric acid and Hyperlipemia
| Article | Year |
|---|---|
Gout and Metabolic Syndrome: a Tangled Web.
Topics: Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Gout; Humans; Hyperlipide | 2017 |
Chronic kidney disease: a marker of cardiovascular disease.
Topics: Albuminuria; Anemia; Biomarkers; Blood Urea Nitrogen; Cardiovascular Diseases; Creatinine; Glomerula | 2009 |
Effects of fibrates on serum metabolic parameters.
Topics: Anticholesteremic Agents; Carbohydrates; Cholesterol, HDL; Clinical Trials as Topic; Coronary Diseas | 2002 |
Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review.
Topics: Adipose Tissue; Arteriosclerosis; Coronary Disease; Fatty Acids, Nonesterified; Fibrinolysis; Flushi | 2005 |
[Other antihyperuricemic agents].
Topics: Antihypertensive Agents; Cardiovascular Diseases; Drug Therapy, Combination; Fenofibrate; Gout; Gout | 2008 |
[Complication of childhood obesity].
Topics: Body Mass Index; Cardiovascular Diseases; Child; Diabetes Mellitus, Type 2; Fatty Liver; Female; Hum | 1995 |
[Obesity and the related diseases: gout].
Topics: Alcohol Drinking; Animals; Female; Gout; Humans; Hyperlipidemias; Male; Obesity; Uric Acid | 1995 |
[Polymetabolic syndrome].
Topics: Albuminuria; Cholesterol; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension; Insulin; | 1995 |
[Hyperuricemia and insulin resistance].
Topics: Cardiovascular Diseases; Cholesterol, HDL; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Humans | 1996 |
[Gout and atherosclerosis].
Topics: Alcohol Drinking; Coronary Artery Disease; Gout; Humans; Hyperlipidemias; Hypertension; Obesity; Pla | 1996 |
[Hyperuricemia].
Topics: Female; Humans; Hyperlipidemias; Hypertension; Male; Uric Acid | 1996 |
Is serum uric acid a risk factor for coronary heart disease?
Topics: Biomarkers; Coronary Disease; Female; Humans; Hyperlipidemias; Hypertension; Male; Risk Factors; Uri | 1999 |
[Insulin sensitizer and urate metabolism].
Topics: Chromans; Diabetes Mellitus, Type 2; Female; Glucose; Gout; Humans; Hyperlipidemias; Hypertension; H | 2000 |
Insulin resistance: a chicken that has come to roost.
Topics: Coronary Disease; Diabetes Mellitus, Type 2; Fibrinolysis; Genotype; Humans; Hyperinsulinism; Hyperl | 1999 |
[Hyperlipidemia in patients with hyperuricemia].
Topics: Diagnosis, Differential; Diet, Fat-Restricted; Dietary Fiber; Exercise Therapy; Gout; Humans; Hydrox | 2001 |
Serum uric acid is not an independent risk factor for coronary heart disease.
Topics: Coronary Disease; Female; Humans; Hyperlipidemias; Hypertension; Male; Risk Factors; Uric Acid | 2001 |
[Multiple risk factor syndrome and hyperuricemia].
Topics: Female; Humans; Hyperlipidemias; Hypertension; Male; Myocardial Ischemia; Obesity; Risk Factors; Uri | 2001 |
[Hyperuricemia and arteriosclerosis].
Topics: Adult; Arteriosclerosis; Coronary Disease; Dehydroepiandrosterone; Female; Gout; Humans; Hyperlipide | 1978 |
Renal and metabolic complications of childhood non-Hodgkin's lymphoma.
Topics: Acidosis; Acute Kidney Injury; Allopurinol; Aluminum Hydroxide; Burkitt Lymphoma; Child; Humans; Hyp | 1977 |
[Therapy of gout].
Topics: Arteriosclerosis; Colchicine; Diabetes Mellitus; Diet; Gout; Humans; Hyperlipidemias; Kidney Calculi | 1977 |
[Etiology of arteriosclerosis].
Topics: Arteriosclerosis; Diabetes Complications; Gout; Humans; Hyperlipidemias; Hypertension; Risk; Smoking | 1978 |
[Role of life style and nutrition in the etiology, prevention and therapy of coronary disease with special reference to lipid metabolism].
Topics: Cholesterol, Dietary; Coronary Disease; Diet, Sodium-Restricted; Dietary Fats; Female; Humans; Hyper | 1979 |
Atherosclerosis and urate metabolism.
Topics: Arteriosclerosis; Coronary Disease; Gout; Humans; Hyperlipidemias; Hyperlipoproteinemia Type IV; Hyp | 1979 |
[Significance of physical activity in the prevention of degenerative heart and vascular diseases?].
Topics: Adult; Age Factors; Arteriosclerosis; Body Weight; Cerebral Hemorrhage; Cerebrovascular Disorders; C | 1976 |
[Inborn errors of metabolism and their significance in urology and nephrology].
Topics: Acidosis, Renal Tubular; Alkaptonuria; Cystinuria; Diabetes Insipidus; Female; Glycine; Gout; Humans | 1976 |
[Selected phsiopathological and clinical aspects of purine metabolism].
Topics: Alkalosis, Respiratory; Diabetes Mellitus; Diuresis; Female; Fructose Intolerance; Glomerular Filtra | 1976 |
Adverse reactions to diuretics.
Topics: Blood Volume; Diuretics; Drug Interactions; Humans; Hyperglycemia; Hyperlipidemias; Uric Acid; Water | 1992 |
Alcohol and the liver: metabolism of ethanol, metabolic effects and pathogenesis of injury.
Topics: Acetaldehyde; Acetates; Alcohol Dehydrogenase; Alcohol Oxidoreductases; Alcoholism; Animals; Blood G | 1985 |
Gout.
Topics: Arthritis; Cardiovascular Diseases; Diabetes Complications; Environment; Gout; Humans; Hyperlipidemi | 1987 |
Complications of thiazide diuretic therapy: an update.
Topics: Alkalosis; Benzothiadiazines; Blood Volume; Coronary Disease; Death, Sudden; Diuretics; Drug Hyperse | 1986 |
The elderly patient. A special case for diuretic therapy.
Topics: Aged; Aging; Cerebrovascular Disorders; Diuretics; Heart Failure; Humans; Hyperglycemia; Hyperlipide | 1986 |
[Lipids and arteriosclerosis].
Topics: Adult; Age Factors; Aged; Animals; Arteriosclerosis; Cats; Cholesterol; Coronary Disease; Dogs; Gout | 1973 |
Nutritional aspects of alcohol consumption.
Topics: Alcoholism; Animals; Cholecalciferol; Choline Deficiency; Ethanol; Fatty Liver; Glutamates; Humans; | 1972 |
Ethanol metabolism and uric acid.
Topics: Acetaldehyde; Alcoholism; Ethanol; Fasting; Gout; Humans; Hyperlipidemias; Ketone Bodies; Lactates; | 1972 |
Type IV hyperlipoproteinaemia.
Topics: Child; Cholesterol; Chylomicrons; Clofibrate; Diagnosis, Differential; Diet Therapy; Dietary Carbohy | 1973 |
Metabolic effects produced by alcohol in the liver and other tissues.
Topics: Acetaldehyde; Acetates; Alcoholism; Coenzymes; Deficiency Diseases; Dietary Carbohydrates; Enzymes; | 1968 |
Precursors and prevention of coronary artery disease. An overview.
Topics: Aging; Coronary Disease; Diabetes Complications; Diet; Female; Humans; Hypercholesterolemia; Hyperli | 1972 |
Epidemiology of coronary heart disease.
Topics: Adult; Aged; Arteriosclerosis; Cholesterol, Dietary; Coronary Disease; Diabetes Complications; Dieta | 1973 |
28 trials available for uric acid and Hyperlipemia
| Article | Year |
|---|---|
The association between uric acid levels and renal function of CKD patients with hyperlipidemia: a sub-analysis of the ASUCA trial.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Disease Progression; Female; Glomerular Filtration Rat | 2020 |
Effects of a Novel Fixed Combination of Nutraceuticals on Serum Uric Acid Concentrations and the Lipid Profile in Asymptomatic Hyperuricemic Patients : Results from the PICONZ-UA Study.
Topics: Aged; Asymptomatic Diseases; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Dietary Supplements; Dr | 2016 |
[Effects of micronized fenofibrate on lipid and uric acid metabolism in patients with hyperlipidemia].
Topics: Adult; Aged; Female; Fenofibrate; Humans; Hyperlipidemias; Hyperuricemia; Hypolipidemic Agents; Lipi | 2009 |
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Comorbidity; Dose-Response Relationship, Dr | 2010 |
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Comorbidity; Dose-Response Relationship, Dr | 2010 |
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Comorbidity; Dose-Response Relationship, Dr | 2010 |
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Comorbidity; Dose-Response Relationship, Dr | 2010 |
Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine.
Topics: Cholesterol; Creatinine; Cysteine; Female; Fenofibrate; Folic Acid; Homocysteine; Humans; Hyperhomoc | 2003 |
Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia.
Topics: Analysis of Variance; Atorvastatin; Blood Glucose; Female; Fenofibrate; Heptanoic Acids; Homocystein | 2003 |
Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia.
Topics: Atorvastatin; Female; Heptanoic Acids; Homeostasis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhi | 2004 |
Effect of fenofibrate on uric acid metabolism in Japanese hyperlipidemic patients.
Topics: Adult; Aged; Female; Fenofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Japan; Male; Middle | 2004 |
The effects of colestipol when combined with clofibrate in the treatment of severe hyperlipidemia. Short-term and long-term studies.
Topics: Alkaline Phosphatase; Cholesterol; Clofibrate; Colestipol; Drug Therapy, Combination; Female; Humans | 1980 |
Effects of nicotinic acid and lovastatin in renal transplant patients: a prospective, randomized, open-labeled crossover trial.
Topics: Adult; Anticholesteremic Agents; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cro | 1995 |
High-protein diets in hyperlipidemia: effect of wheat gluten on serum lipids, uric acid, and renal function.
Topics: Adult; Aged; Creatinine; Cross-Over Studies; Dietary Proteins; Female; Glomerular Filtration Rate; G | 2001 |
The metabolic spectrum of halofenate.
Topics: Blood Glucose; Cholesterol; Clinical Trials as Topic; Clofibrate; Creatine Kinase; Glycolates; Halof | 1975 |
One-year trials with halofenate, clofibrate, and placebo.
Topics: Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Cho | 1976 |
Clofibrate in type II hyperlipoproteinemia.
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Drug Evaluation; Female; Humans; Hypercholesterol | 1976 |
[D-thyroxin in the therapy of type IIa and IIb hyperlipoproteinemias].
Topics: Adult; Aged; Cholesterol; Dextrothyroxine; Humans; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, | 1977 |
Comparison of clofibrate with halofenate in diabetics with hyperlipidaemia.
Topics: Aged; Cholesterol; Clinical Trials as Topic; Clofibrate; Diabetes Complications; Female; Glycolates; | 1977 |
Effects of halofenate and probenecid on serum lipids and uric acid in hyperlipidemic, hyperuricemic adults.
Topics: Adult; Aged; Body Weight; Cholesterol; Clinical Trials as Topic; Female; Glycolates; Halofenate; Hum | 1977 |
A long-term study of the efficacy of oxandrolone in hyperlipoproteinemias.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Cholesterol; Clinical Trials as Topic; Female; Humans | 1978 |
[Effect of uric acid lowering drugs in low dosage in patients with hyperuricemia and hypertriglyceridemia in a randomized group study].
Topics: Adult; Allopurinol; Benzbromarone; Benzofurans; Drug Combinations; Humans; Hyperlipidemias; Male; Mi | 1979 |
[Treatment of hyperlipemia and hyperuricemia with 2-acetamidoethyl-(4-chlorophenyl)-(3-trifluoromethylphenoxy)-acetate (halofenate), a derivative of clofibrate].
Topics: Cholesterol; Clinical Trials as Topic; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Male | 1976 |
Effect of BM 15.075 on lipoprotein concentrations in different types of hyperlipoproteinaemia.
Topics: Benzamides; Cholesterol; Clofibrate; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoprot | 1977 |
Halofenate: an effective hypolipemia- and hypouricemia-inducing drug.
Topics: Adult; Clinical Trials as Topic; Coronary Disease; Depression, Chemical; Female; Glycolates; Halofen | 1973 |
A double-blind comparison of the hypolipidemic and hypouricemic action of halofenate and clofibrate in patients with hyperlipoproteinemia (types III, IV and V).
Topics: Cholesterol; Chylomicrons; Clinical Trials as Topic; Clofibrate; Glycolates; Halofenate; Humans; Hyp | 1973 |
Double-blind crossoer clinical trial of pyridinolcarbamate in peripheral arterial disease (arteriosclerosis obliterans).
Topics: Arteriosclerosis Obliterans; Blood Cell Count; Bradykinin; Carbamates; Cholesterol; Clinical Trials | 1973 |
[First clinical experiences in therapy of hyperuricemia and hyperlipidemia with the clofibrate derivative MK 185].
Topics: Cholesterol; Clinical Trials as Topic; Glycolates; Gout; Halofenate; Humans; Hyperlipidemias; Hypoli | 1973 |
Clinical evaluation of tibric acid (CP 18,524) a new hypolipidemic agent.
Topics: Adult; Aged; Benzoates; Body Weight; Cholesterol; Clinical Trials as Topic; Coronary Disease; Female | 1974 |
[Influence of aluminum nicotinate on serum lipids].
Topics: Adult; Alkaline Phosphatase; Aluminum; Arteriosclerosis; Blood Glucose; Cardiovascular Diseases; Cho | 1969 |
Treatment of essential hypercholesterolemia with clofibrate and nicotinic acid.
Topics: Adult; Anticholesteremic Agents; Blood Glucose; Cholesterol; Clofibrate; Diet Therapy; Female; Human | 1970 |
269 other studies available for uric acid and Hyperlipemia
| Article | Year |
|---|---|
Dyslipidemia may be a risk factor for progression in children with IgA nephropathy.
Topics: Child; Disease Progression; Dyslipidemias; Glomerular Filtration Rate; Glomerulonephritis, IGA; Huma | 2022 |
Mediating effect of metabolic diseases on the relationship between hyperuricemia and coronary heart disease.
Topics: Cholesterol, HDL; Coronary Disease; Humans; Hyperlipidemias; Hyperuricemia; Risk Factors; Uric Acid | 2023 |
Hyperuricemia increases the risk of cardiovascular mortality associated with very high HdL-cholesterol level.
Topics: Cardiovascular Diseases; Cholesterol, HDL; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Hy | 2023 |
[Association between metabolism-related chronic disease combination and prevalence of non-alcoholic fatty liver disease in community residents in Shanghai].
Topics: Adult; Body Mass Index; China; Chronic Disease; Diabetes Mellitus; Female; Gout; Humans; Hyperlipide | 2023 |
The association between serum uric acid and hypertriglyceridemia: evidence from the national health and nutrition examination survey (2007-2018).
Topics: Adult; Cross-Sectional Studies; Humans; Hyperlipidemias; Hypertriglyceridemia; Nutrition Surveys; Ri | 2023 |
The challenges of managing gout in primary care: Results of a best-practice audit.
Topics: Aged; Allopurinol; Clinical Audit; Clinical Chemistry Tests; Clinical Protocols; Colchicine; Comorbi | 2019 |
The Prevalence of Nonalcoholic Fatty Pancreas by Endoscopic Ultrasonography.
Topics: Adipose Tissue; Adult; Aged; Cross-Sectional Studies; Endosonography; Female; Humans; Hyperlipidemia | 2019 |
Sensitive and non-invasive cholesterol determination in saliva via optimization of enzyme loading and platinum nano-cluster composition.
Topics: Ascorbic Acid; Biosensing Techniques; Cholesterol; Cholesterol Oxidase; Electrochemical Techniques; | 2020 |
Association of serum VLDL level with hyperhomocysteinemia in hypertensive patients: A cross-sectional study.
Topics: Aged; Alanine Transaminase; Anthropometry; Blood Pressure; Blood Pressure Determination; Body Mass I | 2021 |
Maternal fish oil supplementation ameliorates maternal high-fructose diet-induced dyslipidemia in neonatal mice with suppression of lipogenic gene expression in livers of postpartum mice.
Topics: Animals; Animals, Newborn; Dietary Sugars; Dietary Supplements; Female; Fish Oils; Fructose; Gene Ex | 2020 |
Effects of Urate-Lowering Therapy on Risk of Hyperlipidemia in Gout by a Population-Based Cohort Study and on
Topics: Adult; Cohort Studies; Female; Gout; Hep G2 Cells; Humans; Hyperlipidemias; Incidence; Kaplan-Meier | 2020 |
Association between serum urate, gout and comorbidities: a case-control study using data from the UK Biobank.
Topics: Adult; Aged; Cardiovascular Diseases; Case-Control Studies; Comorbidity; Diabetes Mellitus; Female; | 2021 |
Effect of consumption of tree tomato juice (Cyphomandra betacea) on lipid profile and glucose con centrations in adults with hyperlipidemia, Ecuador.
Topics: Adult; Alanine Transaminase; Analysis of Variance; Aspartate Aminotransferases; Blood Glucose; Body | 2016 |
24-h urine metabolic profile: is it necessary in all kidney stone formers?
Topics: Adult; Aged; Body Mass Index; Calcium; Citric Acid; Comorbidity; Diabetes Mellitus; Female; Humans; | 2018 |
Effect of a multivitamin preparation supplemented with phytosterol on serum lipids and infarct size in rats fed with normal and high cholesterol diet.
Topics: Animals; C-Reactive Protein; Cholesterol; Cholesterol, Dietary; Dietary Supplements; Hyperlipidemias | 2013 |
Effects on serum uric acid by difference of the renal protective effects with atorvastatin and rosuvastatin in chronic kidney disease patients.
Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Female; Fluorobenzenes; Glomerular Filtration Rate; He | 2014 |
Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
Topics: Adult; Aged; Blood Pressure; Body Mass Index; China; Cross-Sectional Studies; Diabetes Mellitus, Typ | 2014 |
Attenuating the mortality risk of high serum uric acid: the role of physical activity underused.
Topics: Adult; Aged; Asymptomatic Diseases; Cause of Death; Cohort Studies; Diabetes Mellitus; Exercise; Fem | 2015 |
Serum uric acid and its relationship with cardiovascular risk profile in Chinese patients with early-onset coronary artery disease.
Topics: Adult; Asian People; China; Coronary Angiography; Coronary Artery Disease; Echocardiography; Female; | 2015 |
Serum uric acid: an independent predictive marker for coronary artery disease.
Topics: Coronary Artery Disease; Female; Humans; Hyperlipidemias; Hypertension; Male; Uric Acid | 2015 |
Relationship Between Hyperuricemia and Cardiovascular Disease Risk Factors in a Chinese Population: A Cross-Sectional Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alcohol Drinking; Blood Glucose; Blood Pressure; Body Ma | 2015 |
Correlation of the leucocyte count with traditional and non-traditional components of metabolic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; China; Female; Fibrinogen; Humans; Hy | 2016 |
Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males.
Topics: Adult; Aged; Asian People; China; Comorbidity; Diabetes Mellitus; Humans; Hyperlipidemias; Hypertens | 2016 |
Uric acid and left ventricular hypertrophy in Japanese men.
Topics: Adult; Age Factors; Aged; Animals; Asian People; Body Mass Index; Cohort Studies; Creatinine; Diabet | 2009 |
Statins and hypertension.
Topics: Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Creatinine; Female; Glomerular Filtration Ra | 2009 |
Uric acid and left ventricular hypertrophy.
Topics: Adult; Age Factors; Aged; Animals; Asian People; Body Mass Index; Cohort Studies; Creatinine; Diabet | 2009 |
Epidemiological association between uric acid concentration in plasma, lipoprotein(a), and the traditional lipid profile.
Topics: Adolescent; Adult; Aged; Biomarkers; Cardiovascular Diseases; Chi-Square Distribution; Cholesterol; | 2010 |
Overexpression of podocalyxin in megakaryocytes and platelets decreases the bleeding time and enhances the agonist-induced aggregation of platelets.
Topics: Animals; Bleeding Time; Blood Platelets; Hyperlipidemias; Megakaryocytes; Mice; Mice, Mutant Strains | 2010 |
Interaction between serum uric acid and triglycerides in relation to blood pressure.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Biomarkers; Blood Glucose; Blood Pressure; Bod | 2011 |
Gender-specific risk factors for incident gout: a prospective cohort study.
Topics: Adult; Comorbidity; Female; Follow-Up Studies; Gout; Humans; Hyperlipidemias; Hypertension; Incidenc | 2012 |
Lindane-induced biochemical perturbations in rat serum and attenuation by omega-3 and Nigella sativa seed oil.
Topics: Albumins; Animals; Antioxidants; Cholesterol; Creatinine; Fatty Acids, Omega-3; Hexachlorocyclohexan | 2011 |
Oxidative stress and diabetes in pregnant rats.
Topics: Animals; Antioxidants; Congenital Abnormalities; Diabetes Mellitus, Experimental; Female; Gestationa | 2002 |
A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients.
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Body Mass Index; Cardiovascular Dise | 2002 |
A convenient assay of glycoserum by nitroblue tetrazolium with iodoacetamide.
Topics: Blood Glucose; Diabetes Mellitus; Fructose; Glycated Hemoglobin; Humans; Hyperlipidemias; Iodoacetam | 2002 |
Long-term remission from gout associated with fenofibrate therapy.
Topics: Fenofibrate; Gout; Humans; Hyperlipidemias; Hyperuricemia; Hypolipidemic Agents; Lipids; Male; Middl | 2003 |
[Drug-induced hypouricemia: pathophysiology and application to the hyperuricemia with life style related disease].
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Infective Agents; Fanconi Syndrome; Humans; Hyperlipi | 2003 |
Comparison of different risk factors that result in endothelial damage leading to diabetic microangiopathy.
Topics: Adult; Antigens; Diabetes Complications; Diabetic Angiopathies; Endothelium, Vascular; Humans; Hyper | 2003 |
HYPERTRIGLYCERIDEMIA IN GOUT.
Topics: Arteriosclerosis; Black People; Blood Chemical Analysis; Cholesterol; Genetics, Medical; Geriatrics; | 1964 |
BLOOD LIPID AND URIC ACID INTERRELATIONSHIPS.
Topics: Biomedical Research; Blood; Glycerides; Gout; Humans; Hypercholesterolemia; Hyperlipidemias; Lipid M | 1964 |
CORRELATED VARIATIONS OF THE TOTAL LIPEMIA, CHOLESTEROLEMIA, BETA/ALPHA LIPOPROTEIN RATIO AND ORAL GLUCOSE TOLERANCE TEST.
Topics: Biomedical Research; Blood; Blood Glucose; Carbohydrate Metabolism; Cholesterol; Glucose Tolerance T | 1964 |
[CUTANEOUS AND TENDINOUS TUBEROUS XANTHOMATOSIS THROUGH 3 GENERATIONS].
Topics: Angina Pectoris; Blood; Eyelids; Genetics, Medical; Hyperlipidemias; Hyperlipoproteinemia Type I; Hy | 1964 |
[OVER-EXERTION AND METABOLIC DISORDERS].
Topics: Balneology; Blood; Catalase; Fatigue; Humans; Hyperlipidemias; Hypertension; Liver; Metabolic Diseas | 1965 |
Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.
Topics: Aged; Atorvastatin; Coronary Disease; Creatinine; Female; Heptanoic Acids; Humans; Hydroxymethylglut | 2004 |
Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Anthropometry; Blood Glucose; Body Composition; Body Constitution; B | 2004 |
Effect of five cysteine-containing compounds on three lipogenic enzymes in Balb/cA mice consuming a high saturated fat diet.
Topics: Acetylcysteine; Animals; Blood Glucose; Cysteine; Diet; Dietary Fats; Fatty Acid Synthases; Fatty Ac | 2004 |
Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals.
Topics: Acute Disease; Aged; Aged, 80 and over; Brain Ischemia; Case-Control Studies; Cholesterol; Female; F | 2005 |
Effects of a combination of niacin and chromium(III)-chloride on the skin and lungs of hyperlipemic rats.
Topics: Animals; Chlorides; Chromium Compounds; Diet; Female; Glutathione; Hyperlipidemias; Lipid Peroxidati | 2005 |
Protective role of sulphated polysaccharides in abating the hyperlipidemic nephropathy provoked by cyclosporine A.
Topics: Animals; Cholesterol, LDL; Cholesterol, VLDL; Creatinine; Cyclosporine; Hyperlipidemias; Hypolipidem | 2007 |
[Chronic asymptomatic hyperuricemia as a marker of atherogenic risk in children].
Topics: Adolescent; Age Factors; Atherosclerosis; Biomarkers; Blood Glucose; Blood Pressure; Chi-Square Dist | 2007 |
[Uric acid, apo-E and apo-C3 correlation in normo- and hyperlipidemia].
Topics: Adolescent; Adult; Aged; Apolipoprotein C-III; Apolipoproteins E; Biomarkers; Female; Humans; Hyperl | 2007 |
Alcoholic hyperlipaemia.
Topics: Adult; Alanine Transaminase; Alcoholism; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubi | 1967 |
Biological variations in hyperlipidemic children and adolescents treated with fenofibrate.
Topics: Adolescent; Adult; Alkaline Phosphatase; Bilirubin; Child; Child, Preschool; Cholesterol; Fenofibrat | 1981 |
[A longitudinal study of secondary prevention of heart infarct].
Topics: Aftercare; Aged; Blood Glucose; Female; Humans; Hyperlipidemias; Hypertension; Longitudinal Studies; | 1983 |
[Study of the course of development in 84 non-insulin-dependent diabetics over a 5-to-10-year period. Their therapeutic outcome].
Topics: Adult; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic | 1983 |
[Modification of serum uric acid concentration under long-term therapy with the lipid-regulating drug Duolip].
Topics: Clofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Time Factors; Uric Acid | 1983 |
The management of hyperuricaemia.
Topics: Adult; Aged; Follow-Up Studies; Gout; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Myoc | 1984 |
Diversity of clinical features in gouty arthritis.
Topics: Adolescent; Adult; Age Factors; Aged; Arthritis; Child; Female; Gout; Humans; Hyperlipidemias; Hyper | 1984 |
Familial hyper- and hypouricemias in random and hyperlipidemic recall cohorts: the Princeton School District Family Study.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Child, Preschool; Female; Genetic Diseases, Inborn; Hum | 1983 |
[Thyroid and adrenal diagnosis in obesity are not worth while].
Topics: Adult; Aged; Body Weight; Cushing Syndrome; Diabetes Complications; Female; Humans; Hyperlipidemias; | 1983 |
[Risk factors in cerebrovascular disease. A study of 162 patients].
Topics: Aged; Alcoholism; Cerebrovascular Disorders; Diabetes Complications; Female; Heart Diseases; Humans; | 1983 |
[Management of multiple metabolic overcharge].
Topics: Diet; Humans; Hyperglycemia; Hyperlipidemias; Metabolic Diseases; Uric Acid | 1980 |
Erythrocyte sedimentation rate and cardiovascular disease. Results from a population study of women in Göteborg, Sweden.
Topics: Adult; Angina Pectoris; Blood Sedimentation; Cardiovascular Diseases; Cerebrovascular Disorders; Cho | 1982 |
[The cardiovascular risk profile in patients with disorders of glucose tolerance (borderline diabetes) dependent on the heredity of the diabetes].
Topics: Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Glucose Tolerance Test; Humans; | 1981 |
[Blood cadmium level in coronary disease depending on the risk factors].
Topics: Adult; Aged; Cadmium; Coronary Disease; Diabetes Mellitus; Humans; Hyperlipidemias; Hypertension; Mi | 1980 |
Family study of lipid and purine levels in gout patients and analysis of mortality.
Topics: Cholesterol; Female; Gout; Humans; Hyperlipidemias; Lipoproteins; Male; Sex Factors; Triglycerides; | 1980 |
Clinical chemistry determinations for a biracial cohort of 1,605 normal and hyperlipidemic schoolchildren aged 6 to 17.
Topics: Adolescent; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Child; Crea | 1980 |
[Necrosis of the head of the femur in hyperuricaemia (author's transl)].
Topics: Adult; Angiography; Female; Femur Head; Femur Head Necrosis; Humans; Hyperlipidemias; Male; Radionuc | 1980 |
Benzbromarone and fenofibrate are lipid lowering and uricosuric: a possible key to metabolic syndrome?
Topics: Benzbromarone; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Fenofibrate; Gout; Humans; Hyperlipi | 1994 |
Decreased triglyceride levels with low calorie diet and increased renal excretion of uric acid in hyperuricaemic-hyperlipidaemic patients.
Topics: Energy Intake; Humans; Hyperlipidemias; Kidney; Male; Triglycerides; Uric Acid | 1995 |
[Relation between uric acid and lipid metabolism disorders].
Topics: Adult; Humans; Hyperlipidemias; Male; Middle Aged; Uric Acid | 1993 |
Behavioural and biological correlates of serum uric acid: a study of self-defence officials in Japan.
Topics: Aged; Alcohol Drinking; Body Weight; Creatinine; Diabetes Mellitus; Humans; Hyperlipidemias; Hyperte | 1994 |
Variability of lipid phenotypes in hyperuricaemic-hyperlipidemic patients.
Topics: Adult; Apolipoproteins B; Female; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Prospective St | 1994 |
Femoral and coronary atherosclerosis in patients with hyperlipidaemia. Arteriographic findings correlated to clinical and biochemical parameters.
Topics: Absorptiometry, Photon; Adult; Aged; Angina Pectoris; Angiography; Aorta, Abdominal; Aortic Aneurysm | 1994 |
Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia.
Topics: Adult; Analysis of Variance; Blood Glucose; Case-Control Studies; Humans; Hyperinsulinism; Hyperlipi | 1993 |
[Hyperuricemia and atherosclerosis].
Topics: Aged; Arteriosclerosis; Diet, Atherogenic; Gout; Humans; Hyperinsulinism; Hyperlipidemias; Hypertens | 1993 |
Stereoselective disposition of ibuprofen in patients with compromised renal haemodynamics.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Coronary Disease; Diabetes Mellitus; Female; Heart Fa | 1995 |
Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators.
Topics: Cluster Analysis; Diabetes Complications; Diabetes Mellitus; Humans; Hyperlipidemias; Hypertension; | 1996 |
An evaluation of various indices of body weight change and their relationship with coronary risk factors.
Topics: Adult; Blood Pressure; Body Mass Index; Cholesterol; Coronary Disease; Humans; Hyperlipidemias; Hype | 1996 |
Associations between carotid atherosclerosis and high factor VIII activity, dyslipidemia, and hypertension.
Topics: Adult; Age Factors; Aged; Antithrombin III; Arteriosclerosis; Blood Pressure; Carotid Artery Disease | 1997 |
[Lipoprotein profile in patients with isolated hyperuricemia].
Topics: Apolipoproteins; Cardiovascular Diseases; Cholesterol; Humans; Hyperlipidemias; Lipoproteins; Microv | 1996 |
[Hyperuricemia as a risk factor for noninfectious diseases in the inhabitants of Chuvashia].
Topics: Adolescent; Adult; Aged; Diabetes Mellitus, Type 2; Female; Humans; Hyperlipidemias; Hypertension; M | 1997 |
Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami Community Health Study.
Topics: Adult; Anthropometry; Cholesterol, HDL; Cohort Studies; Comorbidity; Coronary Disease; Ethnicity; Fe | 1997 |
[The relationship between body mass index and coronary risk factors].
Topics: Adult; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Glucose Intoler | 1998 |
Lipoproteins in patients with isolated hyperuricemia.
Topics: Adult; Apolipoproteins; Cholesterol; Humans; Hyperlipidemias; Lipoproteins; Male; Middle Aged; Refer | 1998 |
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Homeos | 1998 |
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Homeos | 1998 |
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Homeos | 1998 |
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Homeos | 1998 |
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Homeos | 1998 |
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Homeos | 1998 |
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Homeos | 1998 |
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Homeos | 1998 |
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Homeos | 1998 |
[Urate affection of kidneys and metabolic disturbances in hypertensive patients].
Topics: Biomarkers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Female; Humans; | 1999 |
Effect of fenofibrate on serum uric acid levels.
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Fenofibrate; Humans; Hyperlipidemias | 1999 |
Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia?
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Blood Pressure; Body Mass Index; Causality; Creatinine; Endothe | 1999 |
Metabolic syndrome is associated with changes in D-mannose metabolism.
Topics: Aged; Blood Glucose; Body Mass Index; Cholesterol; Diabetes Mellitus, Type 2; Female; Glucose Intole | 1999 |
Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety).
Topics: Adult; Analysis of Variance; Arteriosclerosis; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabete | 2000 |
[Prevalence of dyslipidemia and its phenotypes in recently diagnosed essential arterial hypertension].
Topics: Adult; Alcohol Drinking; Algorithms; Blood Glucose; Cardiovascular Diseases; Female; Humans; Hyperli | 2000 |
Management of hypertension and dyslipidaemia in patients presenting with hyperuricaemia: case histories.
Topics: Antihypertensive Agents; Arteriosclerosis; Benzothiadiazines; Diuretics; Female; Fenofibrate; Humans | 2000 |
Hyperinsulinemia and insulin resistance related metabolic syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Female; Humans; Hyperglycemia; | 2001 |
Hypophosphataemia: cause of the disturbed metabolism in the metabolic syndrome.
Topics: Blood Glucose; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, | 2001 |
Clinical features of familial gout and effects of probable genetic association between gout and its related disorders.
Topics: Age of Onset; Alcohol Drinking; Body Mass Index; Comorbidity; Creatinine; Cross-Sectional Studies; D | 2001 |
Serum uric acid levels: a useful but not absolute marker of compliance with fenofibrate treatment.
Topics: Adult; Aged; Biomarkers; Female; Fenofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; M | 2001 |
The effects of the addition of micronised fenofibrate on uric acid metabolism in patients receiving indapamide.
Topics: Adult; Aged; Antihypertensive Agents; Apolipoproteins B; Cholesterol; Cholesterol, LDL; Drug Therapy | 2002 |
Direct potentiometric analysis of sodium and potassium in human plasma: evidence for electrolyte interaction with a nonprotein, protein-associated substance(s).
Topics: Blood Proteins; Blood Urea Nitrogen; Calcium; Cholesterol; Creatinine; Hydrogen-Ion Concentration; H | 1977 |
Hyperlipidaemia in patients with Down's syndrome.
Topics: Adolescent; Adult; Cholesterol; Down Syndrome; Fatty Acids, Nonesterified; Humans; Hyperlipidemias; | 1977 |
[Gout in young subjects].
Topics: Adolescent; Adult; Age Factors; Angina Pectoris; Back Pain; Diabetes Complications; Fatty Liver; Fem | 1977 |
The biochemical, clinical, and genetic features of type III hyperlipoproteinemia.
Topics: Adult; Age Factors; Aged; Cholesterol; Coronary Disease; Female; Glucose Tolerance Test; Humans; Hyp | 1975 |
Studies in asymptomatic primary hyperlipidaemia II. Clinical findings.
Topics: Adult; Age Factors; Aged; Alanine Transaminase; Aspartate Aminotransferases; Body Height; Body Weigh | 1975 |
[Frequency and distribution of types of hyperlipoproteinemia with life-shortening risk factors among ambulant patients (author's transl)].
Topics: Cholesterol; Diabetes Complications; Female; Germany, West; Gout; Humans; Hyperlipidemias; Hypertens | 1975 |
[Plasma fibrinogen activity in diabetes mellitus, hyperlipoproteinemia and hyperuricemia (author's transl)].
Topics: Adult; Aged; Blood Coagulation; Diabetes Mellitus; Female; Fibrinogen; Humans; Hyperlipidemias; Lipo | 1976 |
[Therapy of hyperlipemia and hyperuricemia with a combination of clofibrate and an extractive mucopolysaccharide complex].
Topics: Adult; Aged; Arthritis, Rheumatoid; Cholesterol; Clofibrate; Drug Therapy, Combination; Female; Glyc | 1975 |
[Hyperlipoproteinemia and psoriasis].
Topics: Diabetes Mellitus; Female; Humans; Hyperlipidemias; Lipoproteins, VLDL; Male; Psoriasis; Triglycerid | 1976 |
[Metabolism of triglycerides].
Topics: Carbohydrates; Chylomicrons; Humans; Hyperlipidemias; Lipoproteins, VLDL; Triglycerides; Uric Acid | 1977 |
Primary type V hyperlipoproteinemia. A descriptive study in 32 families.
Topics: Adult; Carbohydrate Metabolism, Inborn Errors; Cholesterol; Chylomicrons; Coronary Disease; Female; | 1977 |
An inheritable hyperlipidemic rabbit.
Topics: Animals; Cholesterol; Disease Models, Animal; Humans; Hyperlipidemias; Lipoproteins, LDL; Lipoprotei | 1976 |
The effect of dietary changes on high density lipoprotein cholesterol. The Oslo Study.
Topics: Adult; Body Weight; Cholesterol; Cholesterol, Dietary; Humans; Hypercholesterolemia; Hyperlipidemias | 1979 |
Development of hyperlipidemia associated with increased lipolytic response of isolated adipose tissue cells following prolonged stimulation by an ectopic pituitary tumor.
Topics: Adenylyl Cyclases; Adipose Tissue; Adrenocorticotropic Hormone; Animals; Blood Glucose; Hyperlipidem | 1978 |
[Type V hyperlipemia. 54 cases (author's transl)].
Topics: Adolescent; Adult; Aged; Alcoholism; Blood Protein Electrophoresis; Child; Child, Preschool; Cholest | 1979 |
Genetic studies of atherosclerosis in animals.
Topics: Animals; Arteriosclerosis; Blood Glucose; Blood Pressure; Cattle; Chickens; Cholesterol; Columbidae; | 1977 |
[Diabetes mellitus and coronary disease--common problems in long-term care].
Topics: Adult; Coronary Disease; Diabetes Complications; Female; Humans; Hyperlipidemias; Hypertension; Male | 1979 |
Mechanism and treatment of hypertriglyceridaemia in gout.
Topics: Alcohol Drinking; Allopurinol; Cholesterol; Gout; Humans; Hyperlipidemias; Male; Middle Aged; Obesit | 1979 |
[Coronary risk factors and extent of angiographically proven coronary artery stenoses (author's transl)].
Topics: Angina Pectoris; Arteries; Arteriosclerosis; Constriction, Pathologic; Coronary Angiography; Coronar | 1979 |
Epidemiology of coronary heart disease risk factors in a free-living population.
Topics: Adolescent; Adult; Aged; Argentina; Coronary Disease; Diabetes Mellitus; Electrocardiography; Female | 1979 |
[Non-drug therapy. Diet therapy. Family physician and family medicine].
Topics: Diabetes Mellitus; Diet, Reducing; Humans; Hyperlipidemias; Obesity; Physical Exertion; Physician-Pa | 1979 |
[Clinical study with a new antihyperlipemic combination].
Topics: Adult; Aged; Blood Pressure; Cholesterol; Clofibrate; Drug Combinations; Female; Hemostasis; Humans; | 1977 |
Clinical experience with haemofiltration.
Topics: Blood Urea Nitrogen; Creatinine; Female; Humans; Hyperlipidemias; Hypertension, Renal; Male; Membran | 1977 |
[Pathomorphology of the heart in angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Coronary Vessels; Death, Sudden; Diabetes Complications; Female; Human | 1978 |
The workinghman's diet. II. Effect of weight reduction in obese patients with hypertension, diabetes, hyperuricemia and hyperlipidemia.
Topics: Body Weight; Diet, Diabetic; Diet, Reducing; Evaluation Studies as Topic; Female; Follow-Up Studies; | 1978 |
[Obesity and cardiovascular risk].
Topics: Adult; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hyp | 1978 |
[Metabolic diseases and idiopathic ischemic necrosis of the femoral head in adults (author's transl)].
Topics: Adolescent; Adult; Aged; Alcoholism; Arteriosclerosis; Blood Glucose; Female; Femur; Femur Head Necr | 1978 |
[Procetofen, a new lipid- and urine-acid-reducing substance].
Topics: Cholesterol; Depression, Chemical; Humans; Hyperlipidemias; Hypolipidemic Agents; Propionates; Trigl | 1978 |
[Retinal thromboses with metabolic disturbances (author's transl)].
Topics: Adult; Age Factors; Aged; Female; Glucose; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Lip | 1978 |
[Therapy of alcoholism].
Topics: Acute Disease; Alcohol Withdrawal Delirium; Alcoholic Intoxication; Alcoholism; Avitaminosis; Chroni | 1976 |
[Myocardial infarction: comparative study of principal risk factors in the two sexes].
Topics: Adult; Age Factors; Aged; Blood Glucose; Female; France; Humans; Hyperlipidemias; Hypertension; Lipi | 1976 |
[Occurrence of hyperuricemia in atrioventricular block. (Results of a study of 158 patients with isotopic pacemaker implantations)].
Topics: Adolescent; Adult; Age Factors; Cardiac Surgical Procedures; Child; Female; Gout; Heart Block; Human | 1976 |
[The significance of uric acid as a risk factor in clinical atherosclerosis].
Topics: Arteriosclerosis; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Risk; Uric Acid | 1977 |
Nutritional state and purine metabolism.
Topics: Adult; Age Factors; Aged; Alcohol Drinking; Body Weight; Coronary Disease; Diabetes Complications; D | 1977 |
[The "alcohol-syndrome" from internal medical view (author's transl)].
Topics: Adult; Age Factors; Alcoholism; Anxiety; Fatty Liver; Humans; Hyperlipidemias; Hypertension; Obesity | 1977 |
[Metabolism and adverse effects of ethanol].
Topics: Acidosis; Alcoholic Intoxication; Alcoholism; Animals; Cholesterol; Deficiency Diseases; Dose-Respon | 1977 |
[Transitory diabetes with regressive hyperlipemia and hyperuricemia during acute colchicine poisoning. Report of a case].
Topics: Acute Disease; Colchicine; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Middle Aged; Uric Aci | 1977 |
[Frequency and distribution of risk factors in hearing loss].
Topics: Adolescent; Adult; Aged; Deafness; Female; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; | 1977 |
Effect of increased serum urate levels on virgin rats with no arteriosclerosis versus breeder rats with preexistent arteriosclerosis.
Topics: Animals; Arteriosclerosis; Female; Hyperglycemia; Hyperlipidemias; Hypertension; Male; Oxonic Acid; | 1977 |
[Hyperlipoproteinemia in patients with arteriosclerotic occlusive diseases of the lower extremities].
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Femoral Artery; Humans; Hyperlipidemias; Leg; M | 1977 |
Treatment of type II hyperlipoproteinemia with d-thyroxine.
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Glucose; Cholesterol; Cr | 1976 |
The effect of hypolipidaemic therapy on serum uric acid concentration.
Topics: Adult; Body Weight; Dietary Fats; Fats, Unsaturated; Female; Humans; Hyperlipidemias; Male; Middle A | 1976 |
[Serum cholesterol concentrations in various basic diseases. Studies in 2466 hospital patients].
Topics: Adult; Aged; Body Height; Body Weight; Cholesterol; Female; Hematologic Diseases; Hospital Records; | 1976 |
Bran, hypertriglyceridaemia and urate clearance.
Topics: Cellulose; Cholesterol; Dietary Fiber; Humans; Hyperlipidemias; Male; Middle Aged; Triglycerides; Ur | 1976 |
[Hyperuricaemia and stenotic coronary atherosclerosis. A description of 214 recent cases of myocardial infarction (author's transl)].
Topics: Adult; Aged; Carbohydrate Metabolism; Coronary Disease; Female; Humans; Hyperlipidemias; Male; Metab | 1976 |
[Effect and severity of obesity on serum lipids and serum uric acid].
Topics: Female; Humans; Hyperlipidemias; Lipids; Male; Obesity; Uric Acid | 1976 |
[Metabolic diseases and osteonecroses].
Topics: Adult; Cholesterol; Female; Humans; Hyperlipidemias; Male; Osteonecrosis; Uric Acid | 1976 |
[Uric acid concentration in serum in different types of hyperlipoproteinemia, myocardial infarction and primary gout].
Topics: Adult; Blood Pressure; Body Weight; Cholesterol; Glucose Tolerance Test; Gout; Humans; Hyperlipidemi | 1975 |
Abnormal renal urate homeostasis in systemic disorders.
Topics: Alcoholism; Diabetes Mellitus; Female; Fructose Intolerance; Glomerular Filtration Rate; Glycogen St | 1975 |
Coronary risk factors in New Zealand Maori and European adolescents: The Rotoua Lakes Study 2.
Topics: Adolescent; Body Height; Body Weight; Coronary Disease; Ethnicity; Female; Humans; Hypercholesterole | 1975 |
A contribution to the interrelation of lipid and uric acid metabolism.
Topics: Adult; Aged; Arteriosclerosis; Gout; Humans; Hyperlipidemias; Lipids; Middle Aged; Uric Acid | 1976 |
Empirical relations as interference correctives in multichannel analyzers.
Topics: Acid Phosphatase; Alkaline Phosphatase; Autoanalysis; Bilirubin; Chlorides; Cholesterol; Creatinine; | 1975 |
Hyperuricaemia--to treat or not?
Topics: Alcohol Drinking; Diet; Endocrine System Diseases; Gout; Hematologic Diseases; Humans; Hyperlipidemi | 1975 |
[Clinical-neurological and electromyographical studies of inpatients isolated with selective pigmentary retinopathy].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Diabetes Mellitus; Diabetic Retinopathy; Electroen | 1975 |
Myocardial infarction in young men. Study of risk factors in nine countries.
Topics: Adult; Australia; Body Weight; Cholesterol; Coronary Disease; Diabetes Complications; Germany, West; | 1975 |
[Pigmentary degeneration of the retina: neurological and biochemical findings (author's transl)].
Topics: Adolescent; Adult; Aged; Body Constitution; Child; Diabetes Complications; Electroencephalography; E | 1975 |
[Gout, hyperuricemia and femur head osteonecrosis (FHON)].
Topics: Adrenal Cortex Hormones; Adult; Female; Femur Head Necrosis; France; Gout; Humans; Hypercholesterole | 1975 |
Computer interpretation of laboratory test results.
Topics: Alkaline Phosphatase; Blood Chemical Analysis; Cholesterol; Computers; Evaluation Studies as Topic; | 1975 |
A comparison of the effects of an oral fructose load in hypertriglyceridaemic and normolipidaemic men.
Topics: Adult; Carbohydrate Metabolism, Inborn Errors; Fructose; Fructose Intolerance; Humans; Hyperlipidemi | 1975 |
[A mechanized enzymic method for the determination of uric acid (author's transl)].
Topics: Autoanalysis; Dianisidine; Humans; Hyperlipidemias; Male; Methods; Peroxidases; Spectrophotometry, U | 1975 |
[Cerebral infarctions. Study of their prevention].
Topics: Adult; Aged; Atrial Fibrillation; Contraceptive Agents; Diabetes Complications; Female; Heart Diseas | 1975 |
[Diet, lipids, lipoproteins and glucose tolerance in patients with peripheral obliterating arteriopathy].
Topics: Adult; Arterial Occlusive Diseases; Blood Glucose; Cholesterol; Dietary Carbohydrates; Dietary Fats; | 1975 |
Editorial: Possible reasons for the comparatively high resistance of women to heart disease.
Topics: Adult; Aged; Arteriosclerosis; Female; Heart Diseases; Humans; Hyperlipidemias; Male; Menstruation; | 1976 |
[Which uric acid value is in need of treatment?].
Topics: Allopurinol; Benzbromarone; Citrates; Coronary Disease; Gout; Humans; Hyperlipidemias; Hypertension; | 1976 |
Renal excretion of urate by hyperuricaemic-hyperlipidemic patients.
Topics: Adult; Aged; Humans; Hyperlipidemias; Kidney; Kidney Function Tests; Lipoproteins; Male; Middle Aged | 1992 |
[Ulcerating gout tophi. Surgical therapy in a patient with hyperuricemia, hyperlipidemia and alcohol abuse].
Topics: Alcoholism; Arthritis, Gouty; Cholesterol; Foot Ulcer; Humans; Hyperlipidemias; Liver Function Tests | 1991 |
Hyperuricemia-hyperlipemia association in the absence of obesity and alcohol abuse.
Topics: Adult; Alcohol Drinking; Cholesterol; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; H | 1990 |
[The evaluation of dry chemical laboratory methods. Their value within the framework of step-by-step diagnosis in general medicine].
Topics: Clinical Laboratory Techniques; Diabetes Mellitus; Evaluation Studies as Topic; Humans; Hyperlipidem | 1990 |
[Acute ischemic optic neuropathy. IV. Biochemical changes in the peripheral blood].
Topics: Acute Disease; Aged; Alpha-Globulins; Female; Humans; Hyperlipidemias; Ischemia; Lipids; Male; Middl | 1988 |
[Changes in uric acid and blood lipids in patients with asymptomatic hyperuricemia treated with diet therapy in a rehabilitation procedure].
Topics: Adult; Aged; Combined Modality Therapy; Dietary Fats; Follow-Up Studies; Gout; Humans; Hyperlipidemi | 1989 |
Tubular function of kidney after galactose loading in two patients with glycogen storage disease type XL.
Topics: Adolescent; Adult; Bicarbonates; Fanconi Syndrome; Galactose; Galactosemias; Glycogen Storage Diseas | 1987 |
[Diffuse idiopathic dysmetabolic hyperostosis and metabolic diseases].
Topics: Aged; Blood Glucose; Diabetes Complications; Female; Glucose Tolerance Test; Humans; Hyperlipidemias | 1987 |
Simple carbohydrates in the diet.
Topics: Animals; Coronary Artery Disease; Diabetes Mellitus; Dietary Carbohydrates; Dietary Fats; Dietary Pr | 1987 |
Preventive cardiology for coronary artery disease.
Topics: Cholestyramine Resin; Combined Modality Therapy; Coronary Disease; Humans; Hyperlipidemias; Hyperten | 1985 |
[Bilateral retinal vein occlusions and general risk factors].
Topics: Aged; Constriction, Pathologic; Diabetic Retinopathy; Female; Heart Failure; Humans; Hypercholestero | 1985 |
[Etiology and pathogenesis of sudden deafness].
Topics: Adult; Cardiovascular Diseases; Female; Hearing Loss, Sudden; Humans; Hyperglycemia; Hyperlipidemias | 1985 |
Hyperuricemia and hypertriglyceridemia: metabolic basis for the association.
Topics: Adult; Aged; Creatinine; Dietary Carbohydrates; Fat Emulsions, Intravenous; Female; Glucose; Gout; H | 1985 |
Fructose and uric acid.
Topics: Blood Glucose; Fructose; Humans; Hyperlipidemias; Triglycerides; Uric Acid | 1973 |
Blood-uric-acid levels in familial hypercholesterolaemia.
Topics: Blood; Female; Gout; Hypercholesterolemia; Hyperlipidemias; Male; Statistics as Topic; Uric Acid | 1966 |
Metabolic effects of dehydroepiandrosterone and Atromid in patients with hyperlipaemia.
Topics: Adrenal Cortex Hormones; Androsterone; Anticholesteremic Agents; Blood; Butyrates; Cholesterol; Dehy | 1966 |
[Problems of long-term treatment of hyperlipoproteinemia with clofibrinic acid].
Topics: Blood Glucose; Cholesterol; Clofibrate; Female; Humans; Hyperlipidemias; Lipoproteins; Long-Term Car | 1973 |
Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride.
Topics: Analysis of Variance; Aniline Compounds; Anisoles; Bilirubin; Biphenyl Compounds; Ceruloplasmin; Cit | 1974 |
[Multiple osteonecrosis with type IV hyperlipoproteinemia (author's transl)].
Topics: Adult; Blood Protein Disorders; Bone Diseases; Glucose Tolerance Test; Gout; Hip Joint; Humans; Hype | 1974 |
[Metabolism and blood circulation studies in absolute nutrition deficiency].
Topics: 17-Hydroxycorticosteroids; Acetoacetates; Acidosis; Adrenocorticotropic Hormone; Adult; Blood Circul | 1967 |
[Hyperlipemias due to alcohol].
Topics: Adult; Alcoholism; Body Weight; Cardiovascular Diseases; Cholesterol; Dietary Carbohydrates; Ethanol | 1972 |
Serial lipid and lipoprotein responses to the American Heart Association fat-controlled diet.
Topics: Adipose Tissue; Adult; Body Weight; Cholesterol; Cholesterol, Dietary; Diet Therapy; Dietary Carbohy | 1971 |
Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype.
Topics: Adolescent; Adult; Aged; Blood Protein Electrophoresis; Child; Coronary Disease; Diseases in Twins; | 1973 |
Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
Topics: Adult; Aged; Blood Glucose; Cholesterol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipo | 1973 |
Type 3 hyperlipoproteinaemia.
Topics: Adult; Apoproteins; Autopsy; Blood Glucose; Cholesterol; Chylomicrons; Dietary Carbohydrates; Electr | 1973 |
[Investigations concerning the incidence of disorders of lipid and carbohydrate metabolism in primary gout and symptomless hyperuricaemia (author's transl)].
Topics: Carbohydrate Metabolism; Cholesterol; Coronary Disease; Diabetes Complications; Female; Gout; Humans | 1974 |
Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population.
Topics: Adult; Age Factors; Aged; Blood Glucose; Cholesterol; Chylomicrons; Coronary Disease; Female; Humans | 1974 |
[Coronaropathies in the black African. Clinical, etiological and current epidemiological aspects (apropos of 45 cases)].
Topics: Adult; Age Factors; Aged; Angina Pectoris; Black People; Coronary Disease; Cote d'Ivoire; Diabetes C | 1974 |
Gout and hyperlipidaemia.
Topics: Adult; Aged; Alcohol Drinking; Allopurinol; Aspartate Aminotransferases; Body Height; Body Weight; C | 1974 |
[Contribution to the study of hyperuricemia associated with essential hyperlipidemias. I].
Topics: Adolescent; Adult; Female; Glucose Tolerance Test; Gout; Humans; Hyperlipidemias; Male; Middle Aged; | 1974 |
[Effect of tocopherol nicotinate on serum lipids].
Topics: Adult; Aged; Aspartate Aminotransferases; Blood Glucose; Blood Pressure; Blood Protein Electrophores | 1974 |
Diet, lipids and lipoproteins in patients with peripheral vascular disease.
Topics: Adult; Age Factors; Aged; Alcohol Drinking; Angiography; Arteriosclerosis; Cholesterol; Diabetes Com | 1974 |
[Concentration of uric acid in the serum. Interrelationship between uric acid and age, weight, height, serum lipids, liver function, glucose tolerance as well as basic disorders].
Topics: Adult; Age Factors; Aged; Body Height; Body Weight; Cardiovascular Diseases; Female; Gastrointestina | 1974 |
[Prevention of arteriosclerosis].
Topics: Arteriosclerosis; Cholesterol; Diabetic Angiopathies; Diet Therapy; Female; Gout; Humans; Hyperglyce | 1974 |
Microangiopathy in hyperlipidemia and gout.
Topics: Adolescent; Adult; Age Factors; Aged; Basement Membrane; Biopsy, Needle; Blood Glucose; Body Weight; | 1974 |
Coronary artery disease in young women.
Topics: Adolescent; Adult; Age Factors; Arteriosclerosis; Body Weight; Carbohydrate Metabolism, Inborn Error | 1974 |
Coronary heart disease in young men: a study of seventy patients with a critical review of etiological factors.
Topics: Adult; Australia; Body Height; Body Weight; Cholesterol, Dietary; Coronary Disease; Diabetes Complic | 1973 |
[The prevalence of lipid metabolism disorders in rheumatological diseases].
Topics: Adult; Age Factors; Aged; Arthritis, Rheumatoid; Blood Glucose; Body Weight; Cholesterol; Diabetes M | 1974 |
[Prevention of arteriosclerosis].
Topics: Adult; Arteriosclerosis; Clofibrate; Germany, West; Gout; Humans; Hyperlipidemias; Male; Middle Aged | 1973 |
Plasma lipid levels in gout.
Topics: Cholesterol; Fatty Acids, Nonesterified; Female; Glycerides; Gout; Humans; Hyperlipidemias; Lipids; | 1972 |
[Reciprocal relationship between purine metabolism disorders and arteriosclerotic angioorganopathies].
Topics: Age Factors; Arm; Arterial Occlusive Diseases; Arteriosclerosis; Cholesterol; Diabetes Complications | 1972 |
[Aseptic, primary osteonecrosis of the femur head].
Topics: Alcoholism; Femur Head; Femur Head Necrosis; Gout; Humans; Hyperlipidemias; Ischemia; Obesity; Osteo | 1972 |
[Lipid disorders in gout and in hyperuricemia with myalgia].
Topics: Adult; Aged; Cholesterol; Female; Gout; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Lipop | 1972 |
[Relationship between metabolic diseases and the severity of coronary disease].
Topics: Angina Pectoris; Angiocardiography; Cholesterol; Diabetes Complications; Diabetic Angiopathies; Fema | 1972 |
[Hyperlipidemia and other risk factors in coronary sclerosis].
Topics: Adult; Aged; Cholesterol; Coronary Disease; Diabetes Complications; Glucose Tolerance Test; Humans; | 1972 |
[Idiopathic femur head necrosis with hyperuricemia and dyslipemia in the adult].
Topics: Adolescent; Adrenocortical Hyperfunction; Adult; Aged; Allopurinol; Child; Diet Therapy; Female; Fem | 1972 |
[Changes between 1948 and 1970 in the epidemiology and clinical features of primary gout].
Topics: Adult; Age Factors; Aged; Alcohol Drinking; Blood Protein Disorders; Diabetes Complications; Fatty L | 1973 |
[Hyperlipoproteinemia in out-patients. Occurrence, type distribution and correlation to clinical findings].
Topics: Adult; Age Factors; Aged; Alcohol Drinking; Blood Glucose; Blood Protein Disorders; Body Weight; Dia | 1973 |
Platelets and vascular disease in gout.
Topics: Allopurinol; Analgesics; Arteriosclerosis; Blood Platelets; Colchicine; Diabetes Complications; Gout | 1973 |
[Lipid disorders in gout and hyperuricemias].
Topics: Cholesterol; Female; Gout; Humans; Hyperlipidemias; Lipids; Male; Metabolic Diseases; Phospholipids; | 1973 |
[Long-term therapy of gout and hyperuricemia].
Topics: Allopurinol; Arteriosclerosis; Blood Protein Disorders; Citrates; Colchicine; Diabetes Mellitus; Die | 1973 |
Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction.
Topics: Adult; Age Factors; Aged; Arteriosclerosis; Blood Glucose; Cholesterol; Coronary Disease; Female; Fo | 1973 |
[Does magnesium-orotate improve the effect of lipid lowering drugs?].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Glucose; Body Weight; Cholesterol; Clofibra | 1973 |
[Relation of blood pressure to the body weight index and to metabolic parameters].
Topics: Adolescent; Adult; Age Factors; Aged; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Diet, | 1973 |
[Lesch-Nyhan syndrome].
Topics: Aggression; Athetosis; Bites, Human; Chorea; Glycine; Humans; Hyperlipidemias; Intellectual Disabili | 1973 |
Triglycerides and uric acid.
Topics: Blood Glucose; Fructose; Humans; Hyperlipidemias; Triglycerides; Uric Acid | 1973 |
Familial hyperuricaemia and hypertriglyceridaemia.
Topics: Adolescent; Adult; Alcohol Drinking; Blood Pressure; Cholesterol; Female; Gout; Humans; Hyperlipidem | 1973 |
Hyperlipidaemia in a group of coronary subjects in Sydney.
Topics: Adult; Age Factors; Body Height; Body Weight; Cholesterol; Coronary Disease; Diet; Humans; Hyperchol | 1973 |
[Significance of hyperlipoproteinemia in diabetes mellitus].
Topics: Adult; Cholesterol; Cholinesterases; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathie | 1973 |
Uric acid and coronary heart disease.
Topics: Coronary Disease; Female; Fructose; Humans; Hyperlipidemias; Male; Portugal; Rural Population; Trigl | 1974 |
Proceedings: Gout, hypertriglyceridaemia, and alcohol consumption.
Topics: Alcohol Drinking; Fasting; Gout; Humans; Hyperlipidemias; Male; Obesity; Sulfobromophthalein; Trigly | 1974 |
A clinical syndrome characteristic of primary Type IV-V hyperlipoproteinaemia.
Topics: Abdomen; Adult; Cholesterol; Chylomicrons; Clofibrate; Diabetes Complications; Diet, Reducing; Elect | 1974 |
The association of familial hyperbetalipoproteinaemia with Waardenburg's syndrome.
Topics: Abnormalities, Multiple; Adolescent; Adult; Blood Glucose; Child; Cholesterol; Chromosome Aberration | 1974 |
Observations concerning the incidence of disturbance of lipid and carbohydrate metabolism in gout.
Topics: Arteriosclerosis; Blood Glucose; Body Weight; Cholesterol; Coronary Disease; Diabetes Complications; | 1974 |
Gout and hyperlipidaemia.
Topics: Adult; Aged; Alcohol Drinking; Alkaline Phosphatase; Aspartate Aminotransferases; Beer; Bilirubin; B | 1974 |
[Hyperuricemia due to hypoxanthine-guanine-phosphoribosyltransferase deficiency].
Topics: Adult; Allopurinol; Anemia; Arthritis; Benzofurans; Gout; Humans; Hyperlipidemias; Hypothyroidism; H | 1974 |
[Multiple aseptic bone necrosis in hyperlipidaemia, hyperuricaemia, and latent diabetes mellitus (author's transl)].
Topics: Adult; Allopurinol; Bone Diseases; Clofibrate; Diet Therapy; Dietary Carbohydrates; Femur Head Necro | 1974 |
[Comparative study of triglyceridemia, lipemia, glycemia and weight index in patients with high and normal serum uric acid].
Topics: Adult; Aged; Blood Glucose; Blood Urea Nitrogen; Body Weight; Cholesterol; Gout; Humans; Hyperlipide | 1969 |
Long-term treatment of hyperlipidemic patients with clofibrate.
Topics: Adult; Aged; Body Weight; Cholesterol; Clofibrate; Female; Glucose; Glucose Tolerance Test; Humans; | 1971 |
Bovine blood serum as a substitute for human serum for quality control of the determination of cholesterol and triglyceride.
Topics: Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Autoanalysis; Bilirubin; Blood; Blood Gl | 1972 |
Unexpected death of athletes.
Topics: Adipose Tissue; Adult; Blood Glucose; Body Composition; Coronary Disease; Humans; Hyperlipidemias; L | 1972 |
Abnormal regulation of glucose and fatty acid metabolism in gout.
Topics: Dietary Carbohydrates; Fatty Acids; Fatty Acids, Nonesterified; Glucose; Glucose Tolerance Test; Gly | 1972 |
[Gout, diabetes mellitus and fatty liver].
Topics: Adult; Arteriosclerosis; Body Weight; Diabetes Complications; Fatty Liver; Female; Gout; Humans; Hyp | 1972 |
[Gout and pregnancy. An unusual case with severe hyperlipoproteinaemia].
Topics: Adult; Blood Protein Electrophoresis; Cholesterol; Female; Gout; Humans; Hyperlipidemias; Lipids; Li | 1972 |
Hyperuricemia in health and disease.
Topics: Arteriosclerosis; Arthritis; Blood Group Antigens; Carbohydrate Metabolism; Diabetes Complications; | 1972 |
[Relations between diet and atherosclerosis].
Topics: Adult; Age Factors; Arteriosclerosis; Coronary Disease; Diet; Dietary Carbohydrates; Dietary Fats; D | 1971 |
[Uric acid abnormalities in juveniles. Peculiarities of the clinical picture].
Topics: Adolescent; Adult; Diabetes Complications; Diagnosis, Differential; Fatty Liver; Gout; Humans; Hyper | 1971 |
Hyperuricemia and gout in an employee population.
Topics: Adult; Age Factors; Alcoholism; Coronary Disease; Diabetes Complications; Diuretics; Gout; Humans; H | 1971 |
Heterogeneity on familial hyperlipoproteinemia type II on the basis of fasting plasma triglyceride-cholesterol ratio and plasma cholesterol response to ethyl p-chlorophenoxyisobutyrate.
Topics: Adult; Blood Glucose; Blood Protein Disorders; Cholesterol; Clofibrate; Coronary Disease; Fasting; F | 1971 |
[Gout in the evolution of Von Gierke's disease].
Topics: Adolescent; Adult; Allopurinol; Child; Female; Glycogen Storage Disease; Glycogen Storage Disease Ty | 1969 |
[Diabetic coma and pancreatitis].
Topics: Acute Disease; Acute Kidney Injury; Adult; Aprotinin; Blood Glucose; Cholesterol; Creatinine; Diabet | 1968 |
The effect of [4,4'-(isopropylidenethio)bis(2,6-di-t-butylphenol)] (DH-581) on serum lipids and lipoproteins in human subjects.
Topics: Anticholesteremic Agents; Chemical Phenomena; Chemistry; Cholesterol; Diabetes Complications; Dietar | 1969 |
[Articular manifestations in hyperlipidemia].
Topics: Adolescent; Adult; Aged; Arthritis; Arthritis, Rheumatoid; Child; Child, Preschool; Female; Gout; Hu | 1969 |
Polyneuropathy associated with hyperlipemia.
Topics: Aged; Blood Glucose; Blood Protein Electrophoresis; Cholesterol; Chromatography, Thin Layer; Clofibr | 1969 |
Bilateral parotid gland enlargement and hyperlipoproteinemia.
Topics: Adult; Alcohol Drinking; Blood Glucose; Cholesterol; Diagnosis, Differential; Diet; Female; Glucose | 1969 |
[Value of biochemical syndrome of arteriosclerosis].
Topics: Arteriosclerosis; Humans; Hyperlipidemias; Lipids; Uric Acid | 1969 |
Benign symmetric lipomatosis (Launois-Bensaude adenolipomatosis) with gout and hyperlipoproteinemia.
Topics: Adult; Azathioprine; Blood Protein Electrophoresis; Carbon Isotopes; Female; Glucose Tolerance Test; | 1970 |
[Treatment of hyperlipemias].
Topics: Adult; Cholesterol; Female; Humans; Hyperlipidemias; Lipid Metabolism; Male; Middle Aged; Uric Acid | 1970 |
[Dietary management of hazard factors in cardiovascular diseases].
Topics: Aged; Cardiovascular Diseases; Diabetes Complications; Diet Therapy; Humans; Hypercholesterolemia; H | 1970 |
[Serum-lipid reducing principles--possibilities for treatment. 5. Indications for nicotinic acid and nicotinic acid derivatives].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Body Weight; Cholesterol; Female; Humans; Hyperli | 1970 |
[Current problems of gout].
Topics: Blood Glucose; Cholesterol; Coronary Disease; Diabetes Complications; Female; Gout; Humans; Hypercho | 1970 |
[Diabetes mellitus, hyperlipemia, fatty liver, hypertension in primary gout and their influencing by benzbromaronum].
Topics: Adult; Benzofurans; Blood Glucose; Blood Sedimentation; Colchicine; Creatinine; Diabetes Mellitus; E | 1970 |
[Incidence of hyperlipemia, hyperuricemia, diabetes mellitus, hypertension and overweight in arterial obliterating disease].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Blood Glucose; Body Weight; Cholesterol; Diabetic Angiopat | 1971 |
[Alterations of lipid metabolism in primary gout and hyperuircemia].
Topics: Adult; Aged; Blood Glucose; Cholesterol; Diabetes Mellitus; Fatty Acids; Fatty Acids, Nonesterified; | 1971 |
The aetiology and possible prevention of myocardial infarction.
Topics: Adult; Age Factors; Aged; Calcium; Diabetes Complications; Female; Humans; Hyperlipidemias; Hyperten | 1971 |
[Gout in young patients].
Topics: Adolescent; Adult; Age Factors; Diabetes Complications; Fatty Liver; Gout; Humans; Hyperlipidemias; | 1971 |
Hyperlipoproteinaemia in gout.
Topics: Adult; Aged; Allopurinol; Blood Protein Disorders; Blood Protein Electrophoresis; Cholesterol; Gout; | 1971 |
[Liver pathology in gout].
Topics: Adult; Biopsy; Blood Glucose; Blood Protein Electrophoresis; Body Weight; Cholesterol; Diabetes Comp | 1971 |
[Gout and hyperlipemia].
Topics: Body Height; Body Weight; Cholesterol; Fatty Acids, Nonesterified; Gout; Humans; Hyperlipidemias; Ma | 1967 |
[Hyperuricemia with cerebral paresis. Syndrome of a hereditary purine metabolic disorder].
Topics: Adolescent; Anemia, Macrocytic; Cerebral Palsy; Child; Child, Preschool; Glycine; Humans; Hyperlipid | 1967 |
Hyperlipidemia in primary gout.
Topics: Adult; Age Factors; Aged; Arteriosclerosis; Cholesterol; Fatty Acids; Female; Gout; Humans; Hyperlip | 1968 |
Migratory polyarthritis in familial hypercholesterolemia (type II hyperlipoproteinemia).
Topics: Adolescent; Adult; Arthritis; Blood Sedimentation; C-Reactive Protein; Child; Child, Preschool; Chol | 1968 |
[Gout and diabetes. II. Diabetes and its relation to saluretic-induced diabetes and hyperuricemia].
Topics: Aged; Carbohydrate Metabolism; Chlorothiazide; Cholesterol; Diabetes Mellitus; Female; Gout; Humans; | 1968 |
Idiopathic hyperlipemia and gout.
Topics: Cholesterol; Colorimetry; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Fatty Acids, Nonesterif | 1968 |
[Gout in advanced age].
Topics: Age Factors; Aged; Allopurinol; Bone and Bones; Cardiovascular Diseases; Colchicine; Female; Gout; H | 1968 |
Cutaneous manifestation in combined lipids and urate metabolic disorders.
Topics: Diet Therapy; Female; Follow-Up Studies; Granuloma; Humans; Hypercholesterolemia; Hyperlipidemias; M | 1969 |
Type 3 hyperlipoproteinaemia.
Topics: Adult; Arteries; Blood Protein Electrophoresis; Cholesterol; Coronary Disease; Diabetes Complication | 1969 |
[Basic treatment of coronary atherosclerosis].
Topics: Activities of Daily Living; Angina Pectoris; Anticoagulants; Cholesterol; Cholestyramine Resin; Coro | 1969 |